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SEQUESTERED ALKALOID DEFENSES IN THE DENDROBATID POISON FROG 
OOPHAGA PUMILIO PROVIDE VARIABLE PROTECTION FROM MICROBIAL PATHOGENS 
 
ABSTRACT 
Amphibians produce the majority of their defensive chemicals, however alkaloid 
defenses in poison frogs are sequestered from dietary arthropods. Alkaloids function as a 
defense against predators, and certain types appear to inhibit microbial growth. However, 
alkaloid defenses vary considerably among populations of poison frogs, reflecting 
geographic differences in availability of dietary arthropods. Consequently, 
environmentally driven differences in poison frog alkaloid defenses may have significant 
implications regarding their protection against pathogens. While natural alkaloid mixtures 
in poison frogs have recently been shown to inhibit growth of non-pathogenic microbes, 
no studies have examined the effectiveness of alkaloids against microbes that infect 
frogs. Herein, I examined how alkaloid defenses in the strawberry poison frog, Oophaga 
pumilio, affect growth of the known anuran pathogens Aeromonas hydrophila and 
Klebsiella pneumoniae. Frogs were collected from five locations throughout Costa Rica 
that are known to vary in their alkaloid profiles. Alkaloids were isolated from individual 
skins, and extracts were assayed against both pathogens. Microbe subcultures were 
inoculated with extracted alkaloids to create dose-response curves. Subsequent 
spectrophotometry and cell counting assays were used to assess growth inhibition. GC-
MS was used to characterize and quantify alkaloids in frog extracts, and my results 
suggest that variation in alkaloid defenses lead to differences in inhibition of these 
pathogens. This study provides the first evidence that alkaloid variation in a dendrobatid 
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poison frog is associated with differences in inhibition of anuran pathogens, and offers 
further support that alkaloid defenses in poison frogs confer protection against both 
pathogens and predators. 
  
3 
INTRODUCTION 
Predation and disease are important selective pressures that affect individuals, 
populations, and communities, thereby driving the evolution of highly diversified 
defensive strategies (Edmunds, 1974). Among these strategies, the use of unpalatable or 
toxic compounds as a defense mechanism is a common adaptation present in a variety of 
microorganisms, plants, invertebrates, and vertebrates (reviewed in Wolfe, 2000; Mebs, 
2001; Engel et al., 2002; Fürstenberg-Hägg et al., 2013). Among vertebrates, chemical 
defenses are widely known for protecting against predators, but in some cases, they also 
play a critical role in defending against pathogenic microorganisms (Nicolas and Mor, 
1995). Amphibians, for example, have characteristically thin, permeable integuments and 
often inhabit moist environments that favor the growth of bacteria and fungi; as a result, 
many amphibians have developed defensive systems primarily based on chemicals 
(Bevins and Zasloff, 1990; Nicolas and Mor, 1995; Conlon, 2011a). 
All amphibians have dermal granular glands, which develop during late larval 
stages and proliferate in size and number throughout the integument after metamorphosis 
(Vanable, 1964; Toledo and Jared, 1995). Granular glands are syncytial structures 
enveloped by smooth muscle cells and connected to the epidermis via ducts (Dockray and 
Hopkins, 1975; Neuwirth et al., 1979; Toledo and Jared, 1995). These glands are 
responsible for releasing skin secretions (i.e., chemicals) intended to defend against 
predators, parasites, and pathogens (Toledo and Jared, 1995; Rivas et al., 2009; Conlon, 
2011a, 2011b; Savitzky et al., 2012). Accordingly, amphibian granular glands secrete a 
wide variety of bioactive chemicals in response to stimulation by stress or injury (Toledo 
and Jared, 1995; Roelants et al., 2013), including biogenic amines (Daly et al., 1987; 
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Erspamer, 1994; McClean et al., 2002), peptides and proteins (Rollins-Smith, 2005; 
Conlon, 2011a, 2011b), steroidal bufadienolides (Daly et al., 2004; Erspamer, 1994), 
tetrodotoxin and related analogs (Yotsu et al., 1990; Kim et al., 2003; Cardall et al., 
2004; Daly, 2004; Yotsu-Yamashita et al., 2004), indolic alkaloids (Daly and Garraffo, 
1990; Jeckel et al., 2015a), and an array of lipophilic alkaloids (Daly et al., 2005; 
Saporito et al., 2012). Amphibians synthesize the majority of these chemical defenses 
(Daly, 1995; Toledo and Jared, 1995), but some antimicrobial peptides and metabolites 
are provided by microbial symbionts (Brucker et al., 2008; Harris et al., 2009; Becker 
and Harris, 2010; Loudon et al., 2014), and lipophilic alkaloids are acquired through diet 
(Daly et al., 1994; Saporito et al., 2009). While thousands of unique compounds have 
been identified from amphibian skin secretions over the past several decades (Erspamer, 
1994; Daly, 1995; Daly et al., 2005; Xu and Lai, 2015), research has focused largely on 
synthesized (i.e., antimicrobial peptides) rather than acquired defenses. 
Peptides are well-studied and commonly synthesized defensive compounds 
secreted by the majority of amphibians (Bevins and Zasloff, 1990; Pukala et al., 2006). 
Some peptides play a role in protecting against predators and parasites (Spindel, 2006; 
König et al., 2012), and many are considered key components in the amphibian innate 
immune system due to their broad-spectrum antimicrobial activities (Nicolas and Mor, 
1995; Diamond et al., 2009; Conlon, 2011b). Antimicrobial peptides are amphipathic, 
cationic peptides that are 10-50 amino acid residues in length and express cytolytic 
activity against pathogenic bacteria, fungi, viruses, and protozoa (Nicolas and Mor, 1995; 
Conlon, 2011b). Approximately 1,900 antimicrobial peptides, classified into nearly 100 
families, have been identified from 178 amphibian species in 28 genera (reviewed in Xu 
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and Lai, 2015). At the species level, amphibian skin secretions often contain multiple 
members of a single peptide family (Tennessen and Blouin, 2007); the heterogeneity of 
molecular structure among peptides within each family is substantial, and this is reflected 
in the observed variation of antimicrobial activity and microbe specificity between 
peptides (Tennessen et al., 2009; Conlon, 2011a). The diversity of peptides produced by 
individual amphibian species may confer protection against a wider range of microbes 
compared to those that produce relatively homogenous mixtures, and interactive effects 
between peptides may increase antimicrobial efficacy (Nicolas and Mor, 1995; Simmaco 
et al., 1998b; Zasloff, 2002; Rosenfeld et al., 2006). Not all amphibians secrete 
synthesized antimicrobial peptides, but in general, those that do secrete peptides appear to 
have an advantage in terms of protection from infection (Conlon, 2011b). In contrast, 
amphibians that rely on external and unpredictable sources for defensive compounds 
(e.g., lipophilic alkaloids) are only able to sequester what is available to them, which may 
influence their protection from predators and pathogens (Mina et al., 2015). Lipophilic 
alkaloids represent a suite of acquired chemical defenses that are, in many ways, 
analogous to the diversity of synthesized peptide defenses present in many amphibians. 
Moreover, lipophilic alkaloid defenses provide an opportunity to examine the 
antimicrobial efficacy of sequestered chemical defenses, which has gone largely 
unstudied. 
Poison frogs are a polyphyletic group of brightly-colored anurans that accumulate 
and secrete lipophilic alkaloids sequestered from their diet as a defense. This globally-
distributed assemblage is represented by approximately 150 species from seven lineages 
in the families Bufonidae (Melanophryniscus), Dendrobatidae (alkaloid sequestration 
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evolved independently in Dendrobatinae, Ameerega, and Epipedobates), 
Eleutherodactylidae (Eleutherodactylus), Mantellidae (Mantella), and Myobatrachidae 
(Pseudophryne) (reviewed in Saporito et al., 2012). Experimental evidence of alkaloid 
sequestration in bufonids (Hantak et al., 2013), dendrobatids (Daly et al., 1994), 
mantellids (Daly et al., 1997), and myobatrachids (Smith et al., 2002) suggests that 
poison frogs uptake and store an assortment of lipophilic alkaloids (i.e., alkaloid 
cocktails) obtained from alkaloid-containing dietary arthropods. In particular, mites and 
ants provide the majority of alkaloids identified in poison frogs (Daly et al., 2002; 
Saporito et al., 2004, 2007b, 2009; Takada et al., 2005), though certain classes of 
alkaloids may also be derived from coccinellid beetles (Daloze et al., 1995) and 
siphonotid millipedes (Saporito et al., 2003). The lipophilic alkaloids that poison frogs 
sequester from arthropods are numerous and highly diverse, with over 1,200 unique 
alkaloids identified and separated into 28 different structural classes (Daly et al., 2005; 
Garraffo et al., 2012; Saporito et al., 2012; Jeckel et al., 2015a). Individual poison frogs 
accumulate between one and 69 of these distinct alkaloids in varying amounts (Daly et 
al., 2005; Saporito et al., 2006, 2007a; Mina et al., 2015), although there is no known 
maximum number that can be accumulated; conversely, dendrobatid poison frogs are not 
known to synthesize antimicrobial peptides, although trace amounts of the peptide 
carnosine have been detected in one species of dendrobatid poison frog to date (Daly et 
al., 1984, 1987; Erspamer et al., 1986; Prates et al., 2012; see Jeckel et al., 2015a for 
review). Just as producing a variety of peptides enhances protection from a wider range 
of pathogens (Rosenfeld et al., 2006; Conlon, 2011b), more diverse alkaloid cocktails 
may provide protection from a wider range of pathogens, though this has yet to be tested. 
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Alkaloids in poison frogs appear to function as a defense against predators 
primarily due to their unpalatability, and in some cases, toxicity (Brodie and Tumbarello, 
1978; Stynoski et al., 2014; Hantak et al., 2016; Murray et al., 2016). Additionally, they 
may confer protection against pathogenic microorganisms. For example, the presence of 
alkaloids throughout non-integumentary tissue (including muscle and liver tissues, as 
well as oocytes) in the same relative proportions as in the skin of the bufonid poison frog, 
Melanophryniscus simplex, may indicate that alkaloids play a role in protection from 
internal infection by non-integumentary parasites (Grant et al., 2012). An alkaloid found 
commonly in some dendrobatid poison frogs, pumiliotoxin 251D, may also be a highly 
effective deterrent of a tropical mosquito known to parasitize anurans (Weldon et al., 
2006). Furthermore, individual synthetic and natural alkaloids inhibit the growth of 
common microbes, including the bacteria Bacillus subtilis (gram-negative) and 
Escherichia coli (gram-positive), and the fungus Candida albicans (Macfoy et al., 2005). 
Most recently, natural alkaloid cocktails from geographically separate populations of the 
dendrobatid poison frog, Oophaga pumilio, were found to inhibit growth of those same 
common microbes to varying degrees, suggesting that alkaloid defenses may vary among 
populations in their ability to inhibit microbial growth (Mina et al., 2015). 
The individual alkaloids evaluated for antimicrobial activity by Macfoy et al. 
(2005) were primarily synthetic enantiomers of poison frog alkaloids, although some 
individual natural alkaloids were included. In general, piperidine, pumiliotoxin, and 
pyrrolidine alkaloids were the most inhibitory, and individual alkaloids were most 
effective against B. subtilis and C. albicans, but rarely effective against E. coli (Macfoy 
et al., 2005). Antimicrobial assays testing natural alkaloid cocktails from different 
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populations of O. pumilio, on the other hand, suggest that the bacteria B. subtilis and E. 
coli are more effectively inhibited by alkaloid defenses than the fungus C. albicans (Mina 
et al., 2015). While this may indicate that natural alkaloid defenses of O. pumilio are less 
effective at inhibiting fungal microbes, the ecological relevance of this is unknown as the 
microbes tested were not frog pathogens. 
Alkaloid defenses vary considerably among dendrobatid poison frog species, 
populations, and individuals within populations, but geographically close populations 
generally have more similar alkaloid defenses than geographically distant populations 
(Myers and Daly, 1976; Daly et al., 1987, 2008a; Saporito et al., 2006, 2007a). Although 
certain factors such as species, sex, age, and life stage are important determinants of 
alkaloid variation (Saporito et al., 2010a, 2010b, 2012; Stynoski et al., 2014; Jeckel et al., 
2015b), geographic differences in alkaloid defenses seem to be a direct result of variation 
in the local availability of dietary arthropods (Saporito et al., 2007a). Given that 
antimicrobial activity differs among individual alkaloids (Macfoy et al., 2005) and 
natural alkaloid cocktails (Mina et al., 2015), environmentally-driven differences in  
alkaloid defenses may influence frog protection against natural pathogens at the 
population level. For example, differential resistance among poison frog populations to 
infectious pathogens may correlate with survival probability during outbreaks of 
emerging infectious diseases. Moreover, the combination of geographic and temporal 
differences in pathogen prevalence and variable pathogen protection among poison frog 
populations may influence species distributions and persistence in the wild. Poison frogs 
in captivity may be even more vulnerable since alkaloids are acquired exclusively 
through a specialized diet of alkaloid-containing arthropods (Daly et al., 1994; Saporito 
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et al., 2009); frogs entirely lack defenses if raised in captivity (Daly et al., 1992, 1997; 
Hantak et al., 2013), while frogs collected from nature are left with only the alkaloids 
contained in their granular glands at the time of collection, which can persist for over six 
years in captivity (Myers et al., 1978; St. Claire et al., 2005). As a result of global 
amphibian population declines, ex situ captive breeding programs with the goal of 
facilitating successful reintroductions to the wild have been initiated for a variety of 
endangered amphibians (for review, see Griffiths and Pavajeau, 2008; Harding et al., 
2015), some involving endangered poison frogs (Hunter et al., 2010b; McFadden et al., 
2013; Edmonds et al., 2015). If poison frogs with reduced or absent alkaloid defenses are 
truly more vulnerable to infectious pathogens, captive breeding programs for poison frogs 
may greatly benefit from research that informs management and reintroduction strategies 
that are more likely to succeed, which is crucial in light of contemporary biodiversity loss 
and the global amphibian crisis. 
Population declines and species extinctions resulting in losses of biodiversity are 
occurring at rates that are orders of magnitude higher than the average rate inferred from 
the fossil record (Myers, 1993; Singh, 2002). Of all vertebrate taxa, amphibians are 
experiencing the greatest global biodiversity decline (Stuart et al., 2004), and although 
there are many contributing factors (Blaustein and Kiesecker, 2002), infectious disease 
appears to be a major cause (Daszak et al., 1999). Numerous pathogenic microbes infect 
amphibians, including opportunistic gram-negative bacteria, the chytrid fungus 
Batrachochytrium dendrobatidis (Bd), mycobacteria, ranaviruses, water molds, 
trematodes, and other various parasites (Taylor et al., 2001; Green et al., 2002; Densmore 
and Green, 2007; Schadich and Cole, 2010; Haridy et al., 2014). While the majority of 
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research on amphibian disease in relation to population declines to date has focused on 
Bd, other pathogens are involved as well and have been comparatively understudied (see 
Green et al., 2002; Prada-Salcedo et al., 2011). For example, Aeromonas hydrophila, 
ranaviruses, mycobacteria, and water molds are reported to co-occur with chytrid 
infections in captive and wild populations of frogs (Miller et al., 2008; Hill et al., 2010; 
Prada-Salcedo et al., 2011; Whitfield et al., 2013); therefore, understanding how 
amphibians deal with these other pathogens alone or in co-infection with Bd will provide 
valuable insight into the role of these microbes in amphibian declines. 
Opportunistic gram-negative bacteria can cause bacterial dermatosepticemia, a 
fatal systemic infectious disease in frogs that is implicated in population declines and 
extirpations in the wild (Hunsaker and Potter, 1960; Nyman, 1986; Bradford, 1991; 
Sherman and Morton, 1993) and mass mortalities in captivity (Olson et al., 1992; 
Pearson, 1998; Green et al., 1999; Mauel et al., 2002). Although a variety of gram-
negative bacteria can cause bacterial dermatosepticemia, certain bacteria seem to be 
implicated in the majority of cases (e.g., A. hydrophila). Some bacteria also appear to be 
more virulent than others, dependent on frog species as well as a variety of 
environmental, stress, dietary, health, and immune status factors (Schadich and Cole, 
2010). For instance, Schadich and Cole (2010) isolated A. hydrophila, Klebsiella 
pneumoniae, and Proteus mirabilis from brown tree frogs (Litoria ewingii) during an 
outbreak of bacterial dermatosepticemia in a New Zealand forest; through exposure of 
healthy frogs to the three pathogen isolates, K. pneumoniae was determined to be the 
most pathogenic, despite A. hydrophila typically being the reported causative agent in 
bacterial dermatosepticemia epidemics. Moreover, L. ewingii lacks skin peptide defenses 
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(Schadich, 2009), which supports the idea that chemical defenses in frogs are important 
for protection from these pathogens, considering how susceptible to infection L. ewingii 
appears to be. For instance, resistance of Litoria raniformis to K. pneumoniae is related to 
the antimicrobial activity of its peptide defenses (Schadich et al., 2009), and resistance of 
certain Australian and Central American frogs to Bd is correlated with  the antimicrobial 
activity of peptides (Woodhams et al., 2006a, 2006b, 2007a). Although antimicrobial 
peptide defenses are thought to have evolved as a secondary, broad-spectrum immune 
defense (Nicolas and Mor, 1995; Roelants et al., 2013) and are effective in that role 
(Simmaco et al., 1998b; Zasloff, 2002; Rollins-Smith, 2005), there is a fundamental gap 
in our understanding of the role that sequestered alkaloid defenses serve in defending 
poison frogs from infection. 
Research on the antimicrobial activity of alkaloid defenses in frogs (Macfoy et al., 
2005; Mina et al., 2015) has focused on the strawberry poison frog, O. pumilio, a 
terrestrial dendrobatid frog whose alkaloid defenses are relatively well-characterized and 
vary considerably with geographic location at both small and large spatial scales 
(Saporito et al., 2006, 2007a, 2010a). Moreover, although O. pumilio is not at risk for 
decline due to infectious pathogens, individual and co-occurring infections by pathogenic 
microbes are prevalent in certain populations (Whitfield et al., 2013). The substantial 
variability in O. pumilio alkaloid defenses, in addition to an abundance of previously-
identified alkaloids, makes O. pumilio an ideal study organism in which to examine 
ecologically relevant antimicrobial activity of sequestered alkaloid defenses. The aim of 
the present study is to examine the extent to which the variable alkaloid defenses in a 
dendrobatid poison frog, Oophaga pumilio, inhibit the growth of the anuran pathogens A. 
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hydrophila and K. pneumoniae. Comparing highly variable alkaloid defenses from 
individual O. pumilio with corresponding microbial inhibition allows direct evaluation of 
the extent to which inhibition is driven by alkaloid defenses. On the basis of previous 
studies, I hypothesized that population-level variation in alkaloid defenses will 
differentially inhibit microbial growth, dependent upon the quantity and types of 
alkaloids present. Specifically, populations with greater quantities of alkaloids and more 
diverse alkaloid cocktails are predicted to inhibit microbial growth most effectively. 
 
METHODS 
Study Sites and Frog Collections 
Adult frogs were collected from five sites located in lowland tropical rainforest 
throughout eastern Costa Rica and were selected based on known differences in the 
alkaloid defenses (i.e., number and quantity of unique alkaloids and alkaloid structural 
classes) of O. pumilio from each site (Fig. 1; alkaloid data from Saporito et al., 2007a). 
La Selva Biological Station (10°26' N, 83°59' W) and Finca los Nacientes (10°21’53” N, 
84°8’6” W) are located in Heredia Province. La Selva is a private biological reserve 
managed by the Organization for Tropical Studies, and is dominated by primary forest 
that has experienced minimal human impact since the European colonization of the 
Americas (Whitfield et al., 2012). The other three sites, Tortuguero (10°35’14” N, 
83°31’34” W), Río Palmas (10°10’16” N, 83°36’26” W), and Gandoca (9°35’03” N, 
82°37’13” W), are located throughout Limón Province, which spans the entire eastern 
coast of Costa Rica. 
13 
In order to acquire natural frog alkaloids for microbial growth assays, 14 adult O. 
pumilio were collected from each of the five geographically isolated sites throughout 
Costa Rica (n = 14 frogs per population, N = 70 total). This sample size allowed for 
variation in alkaloid defenses to be examined within and among populations and between 
sexes, and was based on the permission allowed by the government of Costa Rica. At 
each site, a single 45 m × 45 m collection plot was established following the methods of 
Saporito et al. (2006, 2007a, 2010). Selection of a single collection location at each site 
minimized the variation in alkaloid samples obtained within populations since availability 
of dietary arthropods varies geographically and since O. pumilio has a patchy distribution 
throughout its range. Frogs within the delineated plot were collected using hand nets and 
then sexed based on gular skin patches (Donnelly, 1989) until an even sex ratio of seven 
males and seven females were acquired (except at Río Palmas and Finca Los Nacientes, 
where eight males and six females were collected due to difficulty locating females). 
Collected frogs were weighed to the nearest 0.01 g using a Pesola PPS200 digital 
pocket scale, measured for snout-to-vent length (SVL) to the nearest 0.1 mm using 
Control Company Traceable digital calipers, and then euthanized by freezing. Frog skins 
were collected and stored individually in 4 mL of 100% methanol inside sealed glass 
vials with Teflon-lined caps. Each vial was labeled with a unique identifier, allowing for 
extracts to be tracked throughout experimentation and matched to their frog’s collection 
location, sex, weight, and SVL. All methods were approved by John Carroll University 
IACUC protocol #1101 and collection of O. pumilio was approved by CITES collection 
permit 2015-CR1420/SJ(#S1487). 
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Alkaloid Fractionations 
Alkaloids from each of the 70 frog skins were extracted into individual 100 µL fractions 
using an acid-base extraction technique that isolates lipophilic alkaloids from other 
compounds such as fatty acids and carotenoids (original methods outlined in Saporito et 
al., 2010). For each skin sample, 1 mL of the original 4 mL methanol extract was 
transferred to a 10 mL conical vial and acidified with 50 µL hydrochloric acid (1 N) to 
solubilize the alkaloids in water. This solution was then evaporated to a volume of 100 
µL using nitrogen gas, followed by dilution with 200 µL deionized water. Four 
subsequent extractions with 300 µL hexane removed the majority of non-alkaloid 
lipophilic compounds from the samples. The organic hexane layer was disposed of, and 
the remaining aqueous solution containing alkaloids was basified with eight drops of 
sodium bicarbonate such that alkaloids became soluble in ethyl acetate. Once basicity 
was verified with pH paper, three subsequent extractions with 300 µL ethyl acetate then 
separated alkaloids from residual non-alkaloid compounds in the aqueous solution. Each 
time, the ethyl acetate layer was pipetted into a tube with anhydrous sodium sulfate to 
remove remaining trace amounts of water. The total 900 µL of ethyl acetate containing 
alkaloids was transferred to a clean tube and evaporated until dryness with nitrogen gas. 
Alkaloid fractions were immediately resuspended in 100 µL methanol as soon as all 
liquid evaporated, and this 100 µL fraction was transferred to a microvial with a Teflon-
lined cap for use in microbial growth inhibition assays. Alkaloid extractions were 
conducted twice for each frog skin (n = 140 individual fractionations), resulting in a final 
volume of 200 µL alkaloids available for use in microbial growth inhibition assays. The 
two 100 µL alkaloid fractions from each frog were combined to eliminate any variation 
15 
between fractions from the same frog skin, and then the alkaloid fractions from all frogs 
were used in microbial growth inhibition assays (see below). For GC-MS analyses of 
alkaloid fractions, this procedure was carried out one additional time for each skin sample 
(n = 70 individual fractionations), but with the addition of 100 µL nicotine immediately 
after the acidification step as an internal standard. 
 
Culture and Maintenance of Microbes 
All procedures involving microbial cultures and growth assays were performed in a 
HEPA filtered laminar flow hood (SterilGARD Hood, The Baker Company, Sanford, 
ME) with barrier pipet tips (AvantGuard, MIDSCI, St. Louis, MO), and all media was 
sterilized before use by autoclaving at 121°C for 30 minutes. Aeromonas hydrophila 
(ATCC® 35654™) and Klebsiella pneumoniae subsp. pneumoniae (ATCC® 13883™) 
stock cultures were each grown in 50 mL polypropylene conical tubes (SpinMax, 
Crystalgen, Commack, NY) containing 30 mL tryptic soy broth (TSB) (Remel, Thermo 
Scientific, Lenexa, KS), and incubated for 24 hours at 30°C (A. hydrophila) or 37°C (K. 
pneumoniae) in a shaking incubator (New Brunswick Scientific 12400 Incubator Shaker) 
set to 100 revolutions per minute (rpm). All procedures involving incubation and/or 
shaking were conducted under these temperature and agitation conditions. Twelve 1 mL 
stock cultures per microbe were cryopreserved at -80°C (see Cryopreservation of 
Microbes in APPENDIX). Each week, a 10 µL loop from a new thawed stock culture was 
streaked on a tryptic soy agar (TSA) (Teknova, Hollister, CA) culture plate and incubated 
until single colonies formed (typically 8 hours). This ensured viability of single colonies 
that were used to grow cultures for microbial growth inhibition assays. 
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Microbial Growth Inhibition Assays 
Optical Density Assays 
Optical density (OD) assays were adapted from an assay described by Mina et al. (2015). 
To begin each OD assay (n = 2 per population, 10 per microbe, 20 total), a 30 mL TSB 
culture was inoculated with a single pure colony from a streak plate and incubated at 
30°C (A. hydrophila) or 37°C (K. pneumoniae) for 18 hours. Based on pilot growth 
experiments (see Pilot Experiments in APPENDIX), these cultures were diluted with TSB 
to a ratio of 1:10 (A. hydrophila) or 1:5 (K. pneumoniae) immediately prior to 
experimentation, allowing all assayed subcultures to proceed through the logarithmic 
(log) growth phase and into the stationary growth phase within 24 hours. Diluted cultures 
were vortexed (Vortex Genie 2, VWR, Radnor, PA) for 5 seconds and poured into a 
plastic trough (VWR, Radnor, PA), and then equal 200 µL volumes (subcultures) of the 
microbial suspension were immediately aliquotted into 80 wells of a 96-well microplate 
(Falcon, Corning, Tewksbury, MA) using a multichannel pipettor (20 – 200 µL, BioPette 
Plus, Labnet International, Edison, NJ). 
Column 1 on the microplate represented an untreated control, columns 2 – 5 and 7 
– 9 each represented one of seven individual frogs in the assay (inoculation with alkaloid 
extracts from corresponding frogs), and columns 6 and 10 represented vehicle controls. 
Methanol alone served as the vehicle control because alkaloid extracts were dissolved in 
methanol. Excluding column 1, each of the 72 inoculated subcultures per assay were 
inoculated with either 2.4 (rows A – D) or 4.8 µL (rows E – H) of alkaloid extract or pure 
methanol. This resulted in a total of four replicates (subsamples) per volume under each 
treatment (alkaloid or methanol inoculation), except for the untreated control that had 
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eight replicates in each assay. Since the addition of methanol resulted in consistent 
growth inhibition, any subsamples that grew an abnormal amount (> 20%) more than 
untreated controls were considered contaminated and were therefore excluded from 
analyses. Treatment volumes were selected based on pilot experiments which indicated 
that 9.6 µL of methanol in 200 µL of A. hydrophila was highly inhibitory and would 
likely obscure any inhibition due to natural alkaloid extracts; while treatments with 2.4 
µL and 4.8 µL of methanol were inhibitory compared to negative controls, differences 
between methanol and alkaloid treatments were still apparent at these volumes (see Pilot 
Experiments in APPENDIX). Moreover, the treatment volumes are ecologically relevant 
for what microbes may be exposed to on frog skin, representing 0.6% and 1.2%, 
respectively, of the total quantity of alkaloids present in individual frog skins (based on 
calculations from Gronemeyer, 2013). 
 Immediately following inoculation, the microplate was placed in a Fisher 
Scientific Multiskan FC microplate reader inside an incubator (Forma Reach-In 
Incubator, Thermo Fisher Scientific, Marietta, OH) at the microbe’s corresponding 
growth temperature. An initial measurement of each subculture’s OD at 620 nm (OD620) 
was taken prior to incubation to ensure that subcultures in each assay started off at an OD 
similar to those in pilot experiments (± 0.02 OD620 to account for random variation), 
suggesting that they would be in mid-logarithmic (mid-log) growth phase. When initial 
OD was verified, a 24.5-hour program that recorded OD620 of each subculture at 15-
minute intervals after shaking the plate at medium speed for five seconds was initiated to 
create 24-hour growth curves for each treatment (see Appendices 11-30 for growth 
curves). The final OD620 readings of all four subsamples per sample were averaged for 
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use in statistical analyses of OD assays (except in six instances for A. hydrophila and one 
instance for K. pneumoniae, when one subsample in each instance was removed due to 
abnormal growth in 2.4 µL dose treatments). To equalize sample sizes among treatments, 
fourteen of the twenty methanol control samples for each microbe were randomly 
selected for use in statistical analyses. 
 
Colony-forming unit assays 
Colony-forming unit (CFU) assays were conducted to assess the viability of subcultures 
that were exposed to natural alkaloid extracts and methanol treatments for 24 hours. 
Immediately following the final measurement of OD assays, three randomly-selected 
subsamples from each treatment (e.g., four wells inoculated with alkaloid extracts) were 
used in CFU assays. Since some subsamples grew abnormally in pilot experiments (but 
never more than one of four subsamples), three of four subsamples were randomly 
selected for the final analysis. This approach also ensured equal sample sizes across 
treatments. 
 To quantify viable bacteria in each treatment’s subsamples, each of the three 
selected subsamples were serially-diluted in tenfold increments up to 10-7 using 
microplates. Ten microliters of each serial dilution were then plated on TSA in square 6 × 
6 gridded petri dishes (Fisherbrand, Thermo Fisher Scientific, Waltham, MA) and 
incubated for seven hours or until single colonies (i.e., colony-forming units) formed. 
Once CFUs were visible, the number of CFUs at each dilution (10-1 – 10-7) for each 
subsample was recorded. When CFU counts exceeded 30, colonies tended to grow into 
one another and it became difficult to accurately quantify CFUs. Therefore, the serial 
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dilution that grew CFUs nearest to 30 in number, while still being equal to or below 30, 
was used to calculate the original cell density (OCD; CFU/mL; equation below) of each 
subsample. The average of each treatment’s three subsample OCD values was used in 
statistical analyses. 
Original cell density (CFU/mL) = 
(Colony-forming units)
(Dilution factor) × (Volume of aliquot in mL)
 
In the OCD equation, dilution factor refers to the magnitude of dilution of the quantified 
aliquot (e.g., 10-7), and volume of aliquot in mL refers to the volume of each subsample’s 
dilutions that were plated (10 µL in this case, or 0.01 mL). 
 
Alkaloid Analysis 
To determine which unique alkaloids were present in extracts, and in what quantities 
(µg), samples of individual frog extracts containing a nicotine standard (1 µg/10 µL; (−)-
nicotine ≥99%, Sigma-Aldrich) were analyzed using gas chromatography-mass 
spectrometry (GC-MS). For each alkaloid extract, multiple 1 µL aliquots were analyzed 
with a Varian Saturn 2100T ion trap MS instrument coupled to a Varian 3900 GC (using 
a 30 m x 0.25 mm i.d. Varian Factor Four VG-5ms fused silica column). GC-MS analysis 
was carried out using a temperature program progressing from 100°C to 280°C 
(increasing at a rate of 10°C/min) and with helium as the carrier gas (flow rate of 1 
mL/min). Both electron impact (EI) MS and chemical ionization (CI) MS were used to 
analyze samples of alkaloid fractions, with methanol as the CI reagent. In order to more 
accurately estimate the quantity of alkaloids present in each frog’s alkaloid extract, EI-
MS was conducted in triplicate for each frog, while CI-MS was performed once for each 
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frog. In total, four 1 µL samples from each of 70 frogs’ alkaloid extract were analyzed (n 
= 280 GC-MS runs). 
Unique alkaloids were identified from GC-MS output of alkaloid extracts by 
comparing the GC retention times and mass spectra of individual peaks with alkaloids 
previously identified and reported in poison frogs (Daly et al., 2005, 2007, 2008a, 2008b, 
2009; Saporito et al., 2007a; Garraffo et al., 2012; Grant et al., 2012; Fitch et al., 2013; 
Andriamaharavo et al., 2015). The quantity of unique alkaloids present in each frog was 
determined using, from each of the three EI runs per frog extract, the ratio of the average 
area under each alkaloid’s peak and the nicotine standard using Varian MS Workstation 
v.6.9 SPI. Alkaloids that had not yet been reported in the literature (i.e., new alkaloids) 
were characterized and named if they were present in three or more frogs in quantities 
greater than 5 µg total. 
 
Statistical Analysis 
Since alkaloid composition is a collective measure of the number, type, and quantity of 
alkaloids within individual frog skins, multidimensional scaling (MDS) was used to 
visualize differences in alkaloid composition among populations. Analysis of similarity 
(ANOSIM) was used to detect statistical differences in alkaloid composition among these 
populations. Multivariate analyses were based on Bray-Curtis similarity matrices and 
performed using PRIMER-E version 5. 
A nested one-way analysis of variance (ANOVA) was used to examine variation 
of growth inhibition within individual frog alkaloid treatments in both OD and CFU 
assays for each microbe. In all following analyses, averages of the subsamples were used 
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for each sample within each treatment. A two-tailed, unpaired, independent samples t-test 
was used to determine the presence of a dose-response relationship between 2.4 and 4.8 
µL doses in both OD and CFU assays for each microbe. The effects of alkaloids on 
microbial growth were assessed using one-way ANOVA; final optical densities (growth 
inhibition) and CFU/mL after treatment (remaining viable cells) of frog alkaloid and 
methanol treatments in the 4.8 µL treatment were compared among populations and for 
each pathogen. Multiple comparisons (Tukey’s HSD) were used to identify differences in 
microbial growth inhibition of frog alkaloids from each population compared to methanol 
treatments. To determine the effects of frog population and sex on growth inhibition, 
two-way ANOVA was conducted for each assay with microbe. Linear regression 
analyses were performed to assess relationships between alkaloid composition (diversity 
and quantity) and growth inhibition (OD and CFU assays) for each microbe, and to test 
the relationship between OD and CFU assays for each microbe. All parametric statistical 
analyses were performed using SPSS version 14.0 and GraphPad Prism version 6.05. 
 
RESULTS 
Alkaloid Analysis 
GC-MS analysis of 70 Oophaga pumilio from five Costa Rican populations (Fig. 1) 
resulted in the identification of 353 unique alkaloids (including isomers) represented by 
19 different structural classes (see Table 1 for the most common alkaloids identified in 
each population and Table 2 for all identified alkaloids). The majority of these alkaloids 
are derived from mites and ants. In total, 27 new alkaloids in 7 different structural classes 
were identified (Table 3). Alkaloid composition of O. pumilio differed significantly 
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among the five populations (Global R = 0.91; p = 0.001; Fig. 2a), but not between sexes 
(Global R = -0.03; p = 0.966). Frogs from Finca los Nacientes contained the largest 
number and greatest quantity of alkaloids, while frogs from Gandoca contained the 
lowest number of alkaloids and contained similarly low quantities of alkaloids as frogs 
from La Selva (see Table 4 for details on alkaloid composition by population and sex). In 
general, frogs from Tortuguero and Finca los Nacientes contained about three times as 
much alkaloid (in terms of quantity, µg per frog skin) as frogs from La Selva, Río 
Palmas, and Gandoca (Fig. 2b). 
Alkaloid quantity and diversity are also strongly correlated (F1,68 = 49.47, p < 
0.0001; R2 = 0.421; Fig. 3), although the relationship appears to be exponential rather 
than linear. In general, frogs containing higher quantities of alkaloids also possessed 
more diverse alkaloid cocktails, but fewer new types of alkaloids were represented with 
increasing alkaloid quantities.  
 
Dose-Response Relationship between 2.4 µL and 4.8 µL Treatments 
Exposure of both A. hydrophila and K. pneumoniae to increased doses of alkaloid 
treatments indicates that there is a clear dose-response relationship between treatments 
and microbial growth inhibition. With both A. hydrophila and K. pneumoniae, 
respectively, 4.8 µL treatments resulted in consistently lower final optical density 
readings (t138 = 13.19, p < 0.0001; t138 = 10.15, p < 0.0001) and reduced viable cell counts 
(t138 = 8.47, p < 0.0001; t138 = 6.65, p < 0.0001) in comparison to 2.4 µL treatments. In 
accordance with the dose-response relationship, differences in microbial growth 
inhibition between control and alkaloid treatments were more evident in 4.8 µL 
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treatments; therefore, the results for all following assays and comparisons are reported for 
4.8 µL treatments only (Figs. 4 – 8). 
 
Aeromonas hydrophila Optical Density Assays 
Mean optical density of A. hydrophila treated with alkaloid cocktails from the five 
locations of O. pumilio differed significantly among the five populations of O. pumilio 
and methanol controls (F5,78 = 13.04; p < 0.0005; Fig. 4a); however, mean optical density 
of A. hydrophila treated with alkaloids from individual frogs did not differ within 
samples (F18,312 = 1.09; p = 0.3600). The mean optical density of A. hydrophila treated 
with alkaloids from Tortuguero, La Selva, and Finca los Nacientes frogs was significantly 
less than the methanol control, and the mean optical density of A. hydrophila treated with 
alkaloids from Río Palmas and Gandoca frogs was not significantly less than the 
methanol control. There was no interaction between the effects of frog population and sex 
for optical density assays with A. hydrophila (F4,60 = 0.92, p = 0.4590). 
 
Aeromonas hydrophila Colony-Forming Unit Assays 
Mean viable cell density of A. hydrophila treated with alkaloid cocktails differed 
significantly among the five populations of O. pumilio and methanol controls (F5,78 = 
15.89; p < 0.0005; Fig. 4b); however, mean viable cell density of A. hydrophila treated 
with alkaloids from individual frogs did not differ within samples (F12,234 = 0.90; p = 
0.5450). The viable cells recovered from A. hydrophila treated with alkaloids from all 
populations was significantly less than the methanol control. There was a statistically 
significant interaction between frog population and sex in colony-forming unit assays 
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with A. hydrophila (F4,60 = 3.79, p = 0.0080), although there was no difference in original 
cell density between sexes after treatment with alkaloid cocktails from frogs (F1,60 = 0.99, 
p = 0.3240); in other words, the more inhibitory sex varied among populations. 
 
Klebsiella pneumoniae Optical Density Assays 
Mean optical density of K. pneumoniae treated with alkaloid cocktails from the five 
locations of O. pumilio differed significantly among the five populations of O. pumilio 
and methanol controls (F5,78 = 12.67; p < 0.0005; Fig. 5a); however, mean optical density 
of K. pneumoniae treated with alkaloids from individual frogs differed within samples 
(F18,312 = 2.93; p < 0.0005). The mean optical density of K. pneumoniae treated with 
alkaloids from Tortuguero, Finca los Nacientes, and Gandoca frogs was significantly less 
than the methanol control, and the mean optical density of K. pneumoniae treated with 
alkaloids from La Selva and Río Palmas frogs was not significantly less than the 
methanol control. There was no interaction between the effects of frog population and sex 
for optical density assays with K. pneumoniae (F4,60 = 1.99, p = 0.1070). 
 
Klebsiella pneumoniae Colony-Forming Unit Assays 
Mean viable cell density of K. pneumoniae treated with alkaloid cocktails differed 
significantly among the five populations of O. pumilio and methanol controls (F5,78 = 
26.41; p < 0.0005; Fig. 5b); however, mean viable cell density of K. pneumoniae treated 
with alkaloids from individual frogs did not differ within samples (F12,234 = 0.52; p = 
0.8990). The viable cell density of K. pneumoniae treated with alkaloids from all 
populations was significantly less than the methanol control. There was a statistically 
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significant interaction between frog population and sex in colony-forming unit assays 
with K. pneumoniae (F4,60 = 2.81, p = 0.0330), although there was no difference in 
original cell density between sexes after treatment with alkaloid cocktails from frogs 
(F1,60 = 0.14, p = 0.7060); similarly to colony-forming unit assays with A. hydrophila, the 
more inhibitory sex varied among populations. 
 
 
Relationships between Alkaloid Composition and Growth Inhibition 
Alkaloid-based growth inhibition of A. hydrophila was correlated with both alkaloid 
diversity and composition of O. pumilio (Fig. 6). Alkaloid diversity was a moderate 
predictor of growth inhibition by proxy of both OD (F1,68 =  48.60, p < 0.0001, R
2 = 
0.417; Fig. 6a) and CFU assays (F1,68 = 17.92, p < 0.0001, R
2 = 0.209; Fig. 6b). Alkaloid 
quantity was also a moderate predictor of growth inhibition by proxy of both OD (F1,68 = 
53.46, p < 0.0001, R2 = 0.440; Fig. 6c) and CFU assays (F1,68 = 13.79, p = 0.0004, R
2 = 
0.169; Fig. 6d). 
Alkaloid quantity, but not diversity, was a better predictor of growth inhibition of 
K. pneumoniae compared to A. hydrophila (Figs. 6 and 7). Alkaloid diversity was a 
moderately weak predictor of both OD (F1,68 = 19.05, p < 0.0001, R
2 = 0.219; Fig. 7a) 
and CFU assays (F1,68 = 34.22, p < 0.0001, R
2 = 0.335; Fig. 7b). However, alkaloid 
quantity was a comparatively stronger predictor of both OD (F1,68 = 63.35, p < 0.0001, R
2 
= 0.482; Fig. 7c) and CFU assays (F1,68 = 68.73, p < 0.0001, R
2 = 0.503; Fig. 7d) for K. 
pneumoniae. 
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Relationship between Optical Density and Colony-Forming Unit Assays 
Optical density assays and colony-forming unit assays were strongly correlated for both 
A. hydrophila (F1,68 = 80.88, p < 0.0001, R
2 = 0.543; Fig. 8a) and K. pneumoniae (F1,68 = 
85.52, p < 0.0001, R2 = 0.557; Fig. 8b). The patterns in growth inhibition among O. 
pumilio populations were identical between the two assays for both microbes (Figs. 4 
and 5). 
 
DISCUSSION 
Alkaloid-based chemical defenses in poison frogs are unpalatable and/or toxic to a 
variety of invertebrates and vertebrates, and function accordingly as a defense against 
predators (Brodie and Tumbarello, 1978; Fritz et al., 1981; Szelistowski, 1985; Weldon 
et al., 2013; Stynoski et al., 2014; Hantak et al., 2016; Hovey et al., 2016; Murray et al., 
2016). Individual alkaloids and natural alkaloid cocktails from the dendrobatid poison 
frog O. pumilio have also recently been shown to inhibit the growth of microbes that are 
generally considered non-pathogenic (Macfoy et al., 2005; Mina et al., 2015), suggesting 
that alkaloids may provide a dual defense against both predators and microbes. The 
present study supports this hypothesis and demonstrates that sequestered alkaloid 
defenses from various populations of O. pumilio inhibit the growth of microbes that 
infect anurans and contribute to substantial mortality in captivity and in the wild (i.e., 
pathogenic microbes); however, populations of O. pumilio also appear to vary in their 
ability to inhibit these pathogens. 
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Alkaloid defenses from each population of O. pumilio in the present study 
effectively inhibited growth of the opportunistic, gram-negative bacteria A. hydrophila 
and K. pneumoniae. Poison frogs accumulate unique suites of alkaloid defenses gradually 
over the course of their lifetime as they consume alkaloid-containing arthropods 
(Saporito et al., 2009). In the present study, the composition of alkaloid defenses (i.e., 
quantity and diversity) differed significantly among populations (Fig. 2; Table 1), 
reflecting disparities in the type and availability of dietary arthropods at each location 
(Saporito et al., 2007a, 2009, 2012). Similarly, the extent of growth inhibition of both A. 
hydrophila and K. pneumoniae differed significantly among populations (Figs. 4 and 5), 
most likely as a direct result of each population’s distinct alkaloid composition. 
The two components that determine alkaloid composition, alkaloid quantity and 
alkaloid diversity, are strongly correlated in the studied populations of O. pumilio (Fig. 
3). As the quantity of alkaloids in individual frogs increased, so did the number of unique 
alkaloids acquired. Likewise, alkaloid cocktails in the present study inhibited the growth 
of A. hydrophila and K. pneumoniae more effectively as alkaloid quantity and alkaloid 
diversity increased (Figs. 6 and 7). Accordingly, alkaloid cocktails from Finca los 
Nacientes and Tortuguero frogs inhibited growth of A. hydrophila and K. pneumoniae 
most effectively of all populations in both assays (Figs. 4 and 5). Finca los Nacientes 
frogs were protected by alkaloid defenses that were, on average, nearly threefold greater 
in quantity and 40 – 100% more diverse than those La Selva, Río Palmas, and Gandoca 
frogs. Alkaloid cocktails from Tortuguero frogs were comparable in quantity to alkaloids 
from Finca los Nacientes frogs, but were instead similar in diversity to alkaloids from La 
Selva and Río Palmas frogs and higher in diversity than Gandoca (Table 4). 
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Additionally, the predominant alkaloids present in Finca los Nacientes frog alkaloid 
cocktails (comprising about half of the total quantity) included 5,8-disubstitited 
indolizidines, decahydroquinolines, and histrionicotoxins, whereas the most abundant 
alkaloids in Tortuguero frogs (over 60% of the total quantity) were 5,8-disubstituted 
indolizidines and 5,6,8-trisubstituted indolizidines (Table 1). On the basis of these 
findings, larger quantities of more diverse alkaloids provide enhanced antimicrobial 
protection, but 5,8-disubstituted indolizidines, 5,6,8-trisubstituted indolizidines, 
decahydroquinolines, and histrionicotoxins may also be particularly inhibitory alkaloid 
classes. 
All populations of O. pumilio in the present study contained disproportionately 
high quantities and numbers of mite-derived, branched-chain alkaloids, such as 5,8-
disubstituted indolizidines and 5,6,8-trisubstituted indolizidines (Tables 1 and 2), which 
is typical of Costa Rican O. pumilio (Saporito et al., 2007b, 2009, 2011, 2015). However, 
the alkaloid cocktails from the same populations also varied widely in inhibitory efficacy 
despite sharing large proportions of these common mite-derived alkaloids (Figs. 4 and 
5). The large quantities of these common alkaloids present in the more inhibitory Finca 
los Nacientes and Tortuguero frogs suggest that these alkaloids may become particularly 
inhibitory above a certain quantity, which could explain the comparatively reduced 
inhibition by other populations that share these same alkaloids, but in lower quantities. 
Alternatively, Finca los Nacientes frogs also contained distinctly high quantities of ant-
derived decahydroquinoline and histrionicotoxin alkaloids when compared to other 
populations (Table 1), which may also play an important role in Finca los Nacientes 
frogs’ markedly effective inhibition. Although these findings from both mite- and ant-
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derived alkaloids suggest that alkaloid quantity contributes more to microbial growth 
inhibition than alkaloid diversity, the acquisition of such extreme quantities of alkaloid 
defenses presumably takes years to accrue in individual frogs. Interestingly, inhibition by 
La Selva frogs indicates that tremendous quantities of alkaloids, such as those present in 
frogs from Finca los Nacientes and Tortuguero, are not necessary for comparable 
protection. 
In the present study, alkaloid diversity varied considerably, from an average of 26 
unique alkaloids in Gandoca frogs to 54 unique alkaloids in Finca los Nacientes frogs, 
although Tortuguero, La Selva, and Río Palmas frogs contained the average 38 unique 
alkaloids per frog (Table 4). The alkaloid defenses of frogs from La Selva and Gandoca 
were virtually identical in terms of average quantity, but Gandoca alkaloids were about 
25% less diverse than those from La Selva, representing a unique opportunity to compare 
microbial growth inhibition and alkaloid diversity with quantity held constant. In both 
OD and CFU assays with A. hydrophila, Gandoca frog alkaloids were the least inhibitory 
of all populations, in accord with their low diversity. In contrast, La Selva frog alkaloid 
cocktails inhibited A. hydrophila virtually as well as those from Finca los Nacientes and 
Tortuguero, despite having 300% lower quantities of less diverse alkaloids (Fig. 4; Table 
4). This may indicate that microbial inhibition increases at a progressively reduced rate 
after a certain threshold in the quantity and/or diversity of alkaloids (e.g., average 
quantity and diversity of La Selva frogs), and also clearly demonstrates that increased 
alkaloid diversity has the potential to considerably enhance microbial growth inhibition. 
In certain cases, however, a high diversity of alkaloids may not be enough to 
compensate for low quantities of alkaloids. For instance, the alkaloid cocktails of Río 
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Palmas frogs were marginally more diverse than those from Tortuguero frogs (Table 4), 
yet inhibited growth of K. pneumoniae the least effectively of all populations (Fig. 5). 
Such substantially reduced growth inhibition of K. pneumoniae by Río Palmas frog 
alkaloids was most likely a result of having the lowest quantities of alkaloids of all 
populations, despite their high diversity (Table 4). In this case, the average quantity of 
alkaloids in Río Palmas frogs may have been comparatively far below the hypothetical 
threshold quantity after which gains in microbial inhibition diminish. Moreover, if such a 
threshold quantity exists, then particular alkaloid classes are likely required rather than 
any arbitrary suite of alkaloids. Coincidentally, the already low quantities of alkaloids in 
Río Palmas frogs were also evenly distributed among the identified alkaloid structural 
classes, which was not the case in other populations (Table 1). For example, the five 
most abundant alkaloids among Río Palmas frogs were each of a different structural class 
and comprised just 28% of the population’s total ~3,700 µg of alkaloids, whereas the five 
most abundant alkaloids in the more inhibitory Tortuguero frog alkaloid cocktails 
comprised just the two most common structural classes (5,8-disubstituted and 5,6,8-
trisubstituted indolizidines) and 62% of Tortuguero’s total ~14,000 µg of alkaloids 
(Table 1). Accordingly, optimal growth inhibition likely requires certain quantities of 
specific types of alkaloids, although even comparatively low quantities (e.g., Río Palmas) 
and diversities (e.g., Gandoca) of alkaloids can inhibit the growth of these pathogens to 
an extent. 
Alkaloid defenses from all five populations of O. pumilio effectively inhibited 
growth of the opportunistic, gram-negative bacteria A. hydrophila and K. pneumoniae, 
although OD and CFU assays suggest slightly different interpretations of the results 
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(Figs. 4 and 5). For example, growth inhibition approximated by OD assays indicated 
that certain populations of O. pumilio, such as Río Palmas and Gandoca, did not 
effectively inhibit the growth of these pathogens compared to control, which may 
indicate that they are susceptible to infection. However, as evident from CFU assays, 
treatment with alkaloid cocktails from these same locations significantly reduced the 
amount of viable bacterial cells persisting after 24.5 hours in A. hydrophila and K. 
pneumoniae cultures compared to control, which suggests that alkaloid cocktails from 
Río Palmas and Gandoca are effective antimicrobial agents. These observations of 
effective growth inhibition in CFU assays but not OD assays demonstrate the value of 
CFU assays, and may in fact provide a more ecologically valid assessment of 
antimicrobial efficacy. The discrepancies in effective growth inhibition between OD and 
CFU assays for Río Palmas and Gandoca frogs are likely explained by each assay’s 
measured growth variable; OD assays measured the density of both live and dead cells 
suspended in solution, whereas CFU assays evaluated the quantity of viable (i.e., able to 
multiply via binary fission) bacterial cells remaining after treatment with O. pumilio 
alkaloid cocktails. Moreover, OD assays and CFU assays were strongly correlated (Fig. 
8), and the relative patterns of growth inhibition among populations are nearly identical 
between OD assays and CFU assays, wherein the most (Finca los Nacientes and/or 
Tortuguero) and least inhibitory (Río Palmas and/or Gandoca) populations were 
consistent between assays for each pathogen (Figs. 4 and 5). 
On the basis of the relationships among O. pumilio alkaloid quantity, diversity 
and microbial growth inhibition in the present study, the efficacy of alkaloid-based 
microbial growth inhibition appears to increase most notably when alkaloid defenses 
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comprise sufficient (e.g., >400 µg per frog skin) quantities of diverse suites of alkaloids 
(e.g., >30 individual alkaloids), and when there are high quantities of certain types of 
alkaloids. Consequently, although the general quantity and diversity of alkaloids in 
poison frog defenses undoubtedly drive variation among populations, the presence of 
specific types of alkaloids also likely plays an important role in microbial growth 
inhibition. Overall, these findings support the hypothesis that alkaloid defenses from 
distinct populations of O. pumilio inhibit pathogens to different degrees, which may 
influence how those populations respond to emerging infectious pathogens. 
Mina et al. (2015) reported similar findings, concluding that the only one of their 
five studied O. pumilio populations to effectively inhibit growth of all three of the non-
pathogenic microbes (B. subtilis, E. coli, and C. albicans) also had the highest quantity 
and diversity of alkaloids. On the basis of findings from the present study and Mina et al. 
(2015), poison frogs that sequester greater quantities and types of alkaloids (e.g., longer-
lived individuals that have accrued more alkaloids than younger sympatric individuals, or 
populations that have access to arthropods with more and diverse alkaloid defenses) may 
benefit from a more effective antimicrobial defense (Jeckel et al., 2015b). However, the 
composition of alkaloid cocktails from O. pumilio in the present study suggests that 
alkaloid diversity accumulates rapidly in individual frogs and levels off between 40 and 
60 alkaloids, whereas alkaloid quantity increases indeterminately at a reduced rate (Fig. 
3). Diversity is presumably limited as such because the assemblages of available dietary 
arthropods produce a finite number of unique alkaloids. Moreover, since growth 
inhibition increases with alkaloid diversity (Figs. 6 and 7; Mina et al., 2015), this 
diversity limit may also entail diminishing gains in microbial inhibition as the maximum 
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diversity is approached. Conversely, the quantity of alkaloid defenses in individual O. 
pumilio is most likely limited only by the number and size of granular glands in the skin 
(Saporito et al., 2010b), although a maximum alkaloid volume has not yet been 
described. As a result, it is feasible that alkaloid quantity could virtually accrue 
indefinitely. While massive quantities of alkaloids would in all probability only increase 
the antimicrobial efficacy of a frog’s alkaloid defenses, results from the present study 
seem to indicate that inhibitory activity is increased at progressively reduced rates past a 
certain quantity. Of course, this hypothetical threshold quantity would likely be entirely 
dependent on the specific alkaloids present in skin secretions, as well as the identity of 
the invading pathogen. 
Individual alkaloids inhibit the growth of the bacteria B. subtilis and E. coli to 
varying degrees or not at all (Macfoy et al., 2005), which indicates that alkaloid types 
differ in their inhibitory activity against specific types of microbes (e.g., gram-negative or 
gram-positive bacteria, or various fungi, viruses, etc.). For instance, Macfoy et al. (2005) 
report that nearly all individual assayed alkaloids inhibited the growth of B. subtilis, 
whereas only a piperidine alkaloid inhibited E. coli. Similarly, certain individual 
pyrrolidine, piperidine, decahydroquinoline, and pumiliotoxin alkaloids effectively 
inhibited growth of the fungus C. albicans (Macfoy et al., 2005). In contrast, Mina et al. 
(2015) reported that C. albicans was inhibited only by Isla Solarte (Panama) frog alkaloid 
cocktails containing primarily decahydroquinolines and pumiliotoxin alkaloids, although 
alkaloid cocktails from Puerto Viejo (Costa Rica) frogs, consisting of large amounts of 
decahydroquinolines and histrionicotoxins, also inhibited C. albicans somewhat 
effectively. These findings are consistent with results from the present study in 
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concluding that certain alkaloid classes such as decahydroquinolines and 
histrionicotoxins, which are unbranched-chain alkaloids derived from ants (Spande et al., 
1999; Daly et al., 2005; Jones et al., 2012), may be particularly inhibitory. However, 
microbial inhibition by alkaloid defenses appears to be influenced by more than just the 
presence of specific alkaloid types. 
Important complementary and/or synergistic relationships among sequestered 
alkaloids may enhance protection from pathogens in poison frogs. For example, while the 
aforementioned individual alkaloids differ in terms of which types of bacteria they can 
inhibit (Macfoy et al., 2005), natural alkaloid cocktails from O. pumilio that contain a 
diversity of alkaloids consistently inhibit the same bacteria (Mina et al., 2015). In 
synthesized amphibian chemical defenses, such as antimicrobial peptides, a combination 
of various peptides is more effective than the individual peptides at inhibiting pathogenic 
microbes, including A. hydrophila (Rollins-Smith et al., 2002b; Rollins-Smith, 2005; 
Rosenfeld et al., 2006; Conlon, 2011a). Additionally, more diverse suites of peptides 
have been proposed to provide protection from a wider range of pathogens by enhancing 
other peptides’ inhibitory activity (i.e., synergy), or by different peptides or classes 
targeting different classes of microbes (i.e., complementary) (Nicolas and Mor, 1995; 
Simmaco et al., 1998b; Zasloff, 2002; Tennessen et al., 2009). Based on previous 
alkaloid-based microbial inhibition research and relationships between inhibition and 
alkaloid composition from the present study, similar synergistic and/or complementary 
effects may occur in sequestered alkaloid defenses, where comparatively diverse alkaloid 
cocktails provide enhanced protection from a wider range of pathogens. 
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Relatively little is known about the antimicrobial function of sequestered 
alkaloids in the skin of dendrobatids. However, synthesized antimicrobial peptide 
defenses are common among amphibians, and are considered effective as an innate 
defense against pathogens and in preventing wound infection (Zasloff, 1987; Nicolas and 
Mor, 1995; Simmaco et al., 1998b). Frog species with greater quantities of diverse suites 
of antimicrobial peptides appear to be better protected (Zasloff, 2002; Tennessen et al., 
2009), and the expression of antimicrobial peptides defenses increases following 
infection (Miele et al., 1998; Pask et al., 2012). Although antimicrobial peptides in Rana 
pipiens have been shown to degrade fairly quickly (i.e., active for 15 minutes to 2 hours), 
this is hypothesized to represent a compromise between limiting pathogen infection 
intensity in critical situations and harm to residential, potentially beneficial microbiota 
(Woodhams et al., 2007b; Conlon, 2011b; Pask et al., 2013). The duration that secreted 
alkaloids remain on the skin is not yet known in dendrobatids, although alkaloids are 
unlikely to degrade similarly to antimicrobial peptides and would likely represent a 
comparatively constant first line of defense against microbial pathogens encountered in 
the environment. While most amphibian antimicrobial peptides form pores in the plasma 
membrane of gram-negative bacteria to disrupt cellular membranes and subsequently 
disintegrate the cells (Yang et al., 2001; Brogden, 2005; Diamond et al., 2009; Chen et 
al., 2012), little is known about the antimicrobial capacity and mechanism of action of 
poison frog alkaloids. 
Lipophilic alkaloids in poison frogs vary in their neuromuscular modes of action 
by structural class, but in general block or prevent the inactivation of sodium channels 
and nicotinic acetylcholine receptors (Daly and Spande, 1986; Daly et al., 1999; 
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reviewed in Santos et al., 2016). The various classes of alkaloids may have antimicrobial 
mechanisms of action that correspond to those observed in muscles and neurons, or they 
may act in a yet unknown way to disrupt normal bacterial processes. Moreover, classes of 
alkaloids that differ in their mechanism of action most likely vary in their antimicrobial 
efficacy and the type of microbes they are effective against (e.g., gram-positive or gram-
negative bacteria, fungi, or viruses, which differ widely in structure). Lipophilic alkaloids 
are not amphipathic like antimicrobial peptides and therefore cannot induce pore 
formation to disrupt microbial membranes. However, much like lipid-binding properties 
enhances cytotoxicity in antimicrobial peptides (Mahalka and Kinnunen, 2009), the 
lipophilic properties of sequestered alkaloids may facilitate binding to microbial cell 
membranes and/or uptake into the cells. Sequestered alkaloids may therefore be able to 
depolarize bacterial membranes by binding to various ion channels (Saimi et al., 1998), 
which could result in solute influx or efflux that disrupts microbial cells, or they could 
possibly have intracellular targets that influence their antimicrobial activity. For example, 
many alkaloids act as antimicrobials through the inhibition of efflux pumps (i.e., active 
transport pumps) (Markham et al., 1999; Maurya et al., 2013; reviewed in Cushnie et al., 
2014), and certain indolizidine alkaloids have been proposed to inhibit nucleic acid 
synthesis (Rao and Vekatachalam, 2000). Although very little is known about the 
antimicrobial activity of poison frog alkaloids, these types of microbial interactions may 
allow frog alkaloids to kill bacteria directly (i.e., bactericidal action) and/or inhibit 
bacterial reproduction (i.e., bacteriostatic action). 
Alkaloid defenses in poison frogs may provide dual predator and pathogen 
protection. For example, prospective predators that sample and ultimately reject poison 
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frogs as a prey item (Brodie and Tumbarello, 1978; Fritz et al., 1981; Szelistowski, 1985; 
Gray et al., 2010; Stynoski et al., 2014; Hantak et al., 2016; Hovey et al., 2016; Murray 
et al., 2016) stimulate the secretion of defensive alkaloids onto the skin, and may inflict 
wounds that could be potentially fatal if infected. In this case, poison frog alkaloid 
secretions could potentially reduce wound infection and inhibit the growth of non-
residential microbes including pathogens. However, it should be noted that a resident 
microbiota community almost certainly persists in the presence of alkaloid defenses 
(Culp et al., 2007; Lauer et al., 2007; Walke et al., 2015). Additionally, it is feasible that 
incipient infections in poison frogs may elicit a stress response that stimulates smooth 
muscle around granular glands, thereby inducing the secretion of additional alkaloids 
onto the skin to reduce the viable infection load. For instance, Rana esculenta and 
Bombina orientalis induce and/or upregulate synthesized antimicrobial peptide defenses 
after exposure to microbes, including A. hydrophila (Miele et al., 1998; Simmaco et al., 
1998a; Mangoni et al., 2001). Sequestration of arthropod-derived alkaloids by poison 
frogs may therefore be analogous in some ways to synthesized peptide defenses (Zasloff, 
1987; Pask et al., 2013) and play an important role in protection from infectious 
pathogens, especially when the innate immune system is compromised or the frog is 
wounded. 
 Amphibians are inhabited by communities of microbes (e.g., gut-associated 
microbes and skin-associated microbes), some of which are symbiotic and complement 
their innate immune system by defending the host from infectious pathogens (Culp et al., 
2007; Lauer et al., 2007, 2008; Woodhams et al., 2007c; Myers et al., 2012; Park et al., 
2014; Becker et al., 2015). Conversely, certain gram-negative gut- or skin-resident 
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microbes that are frequently isolated from wild and captive frogs, such as A. hydrophila 
and K. pneumoniae (Hunsaker and Potter, 1960; Lee and Franz, 1973; Hird et al., 1981, 
1983; Bradford, 1991; Barra et al., 1998), can cause fatal systemic infections (i.e., “red-
leg syndrome”; Rigney et al., 1978; Taylor et al., 2001) in immunocompromised 
amphibians (Carr et al., 1976; Hubbard, 1981; Pearson, 1998). Of these microbes, A. 
hydrophila in particular has been linked to wild and captive population amphibian 
declines (Nyman, 1986; Pearson et al., 2000; Huys et al., 2003; Miller et al., 2008; Hill et 
al., 2010). The resistance and resulting virulence of A. hydrophila appears to be due to its 
production of extracellular proteases that break down amphibian antimicrobial peptides, 
rendering these synthesized chemical defenses largely ineffective (Rollins-Smith et al., 
2002a; Schadich and Cole, 2009). Metabolites of Phyllomedusa distincta skin microbiota 
also effectively inhibited growth of E. coli and other microbes in an optical density-based 
growth inhibition assay, whereas A. hydrophila was most resistant to growth inhibition. 
Additionally, K. pneumoniae was not inhibited by the same metabolites, although in a 
separate streak assay (Brito de Assis et al., 2016). In the present study, alkaloid cocktails 
from all populations of O. pumilio clearly inhibited the resistant pathogen A. hydrophila 
and the relatively resistant, occasionally more pathogenic, K. pneumoniae. The 
conclusion that poison frog alkaloids can reliably inhibit A. hydrophila may indicate that 
the extracellular proteases produced by the pathogen are inactive against sequestered 
alkaloids, especially given that those proteolytic compounds confer A. hydrophila 
resistance to antimicrobial peptides (Rollins-Smith et al., 2002a; Tennessen et al., 2009; 
Brito de Assis et al., 2016). This is consistent with the hypothesis that A. hydrophila 
proteases coevolved specifically with widespread amphibian chemical defenses, such as 
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synthesized peptides or microsymbiont-derived metabolites, as an adaptation to survive 
on amphibian skin (Schadich and Cole, 2009). Alternatively, the mechanism of action of 
poison frog alkaloids may simply be more effective against A. hydrophila and K. 
pneumoniae than that of the antimicrobial peptides and metabolites studied so far. 
However, the same antimicrobial peptides that do not inhibit A. hydrophila can 
effectively inhibit the pathogen most closely associated with global amphibian population 
declines and biodiversity loss, Batrachochytrium dendrobatidis (Berger et al., 1998; 
Rollins-Smith et al., 2002b). The inhibitory activity of sequestered alkaloid defenses 
against Bd is not yet known. Thus, although findings from the present study demonstrate 
that poison frog alkaloids can function as an effective defense against virulent pathogens, 
the inhibitory activity of alkaloid defenses against other highly-relevant pathogens 
remains to be determined. 
The chytrid fungus Bd is the primary pathogen implicated in disease-related 
amphibian declines (Blaustein et al., 2012). Nonetheless, various other pathogens 
including ranaviruses, water molds, and mycobacteria frequently co-occur with chytrid 
and one another (Miller et al., 2008; Hill et al., 2010; Prada-Salcedo et al., 2011; 
Hoverman et al., 2012; Souza et al., 2012; Whitfield et al., 2013; Warne et al., 2016), 
and likely contribute to disease dynamics and amphibian population declines. Numerous 
poison frog species are endemic to habitats in which these pathogens are prevalent and 
amphibian population declines have been observed (Hunter et al., 2010a; Catenazzi et al., 
2011; Whitfield et al., 2012; Agostini et al., 2015; Rodríguez-Brenes et al., 2016). 
Moreover, although the Malagasy lineage of Mantella poison frogs is endemic to 
localized habitats that have not yet experienced pathogen-related amphibian declines, low 
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infection loads of Bd and ranavirus infection have recently been detected in sympatric 
native amphibians, and these habitats are climatically suitable for the establishment and 
potential outbreak of the aforementioned pathogens (Kolby, 2014; Bletz et al., 2015; 
Kolby and Skerratt, 2015; Kolby et al., 2015). The presence of Bd and other pathogens is 
also unlikely to be eliminated from the environment, so effective treatment strategies for 
a range of pathogens are imperative in order to facilitate the persistence of natural frog 
populations in situ, and mitigate amphibian biodiversity decline. Treatment with 
antimicrobial peptides appears to be an effective treatment for clearing infection in 
diseased amphibians, particularly for those lacking antimicrobial peptides (Woodhams et 
al., 2012). Conversely, although these treatments are beneficial for treating infected 
amphibians, they do not provide an effective long-term survival solution. Probiotic 
bioaugmentation, wherein amphibians are supplemented with cutaneous bacteria that 
produce antimicrobial metabolites and promote survival in infected frogs (Lam et al., 
2010; Becker et al., 2011; Flechas et al., 2012; Woodhams et al., 2014), has been 
proposed as a feasible in situ and ex situ conservation approach to mitigate disease 
prevalence and mortality in at-risk amphibian species and communities (Muletz et al., 
2012; Bletz et al., 2013; Woodhams et al., 2016). However, poison frogs, which 
effectively lack synthesized peptide defenses (Daly et al., 1984, 1987; Erspamer et al., 
1986; Prates et al., 2012) and have not been examined for bacterial communities, may 
resist or be less receptive to probiotic bioaugmentation as a consequence of the toxic 
sequestered alkaloids in their skin secretions. 
A prospective alternative for endangered or at-risk poison frogs may be dietary 
supplementation with alkaloids, which would facilitate the accumulation of sequestered 
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defenses. Based on results from this study, alkaloid supplementation could potentially 
inhibit the growth of pathogens in captive poison frogs and upon reintroduction to their 
natural habitat. Especially considering that the amphibian immune system is significantly 
impaired during metamorphosis (Rollins-Smith, 1998), such an approach would be 
particularly important for poison frogs raised in captivity (e.g., certain ex situ 
conservation programs, or zoo collections), which would not have had access to alkaloid-
containing dietary arthropods that occur in their natural habitat. In some amphibians, 
synthesized peptides and bacterial symbionts provide protection from disease in 
embryonic, larval, and juvenile life stages (Banning et al., 2008; Walke et al., 2011; Pask 
et al., 2013; Holden et al., 2015). However, comparable defenses have not been identified 
in poison frogs, which underscores the importance of their sequestered alkaloids, 
particularly in earlier life stages. For instance, maternal provisioning of alkaloids via 
nutritive eggs is the sole source of alkaloid defenses for dendrobatid poison frog tadpoles 
of the genus Oophaga, wherein these provisioned alkaloids provide critical early 
protection from predators (Stynoski et al., 2014). On the basis of the present study, 
provisioned alkaloids may also reduce susceptibility to microbial pathogens through the 
critical transition to metamorphosis. Although maternal provisioning of alkaloids appears 
to be unique to members of the genus Oophaga poison frogs, it is conceivable that 
analogous alkaloid supplementation of other poison frogs in the early stages of life would 
enhance resistance to infectious pathogens, which is critical for endangered poison frogs. 
A variety of poison frogs are represented in conservation programs (McFadden et 
al., 2013; Edmonds et al., 2015), but little is known about how sequestered alkaloids 
protect them from infectious pathogens, or how alkaloids may be utilized to their 
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advantage. For example, certain Australian Pseudophryne frogs were extirpated from the 
wild by Bd and are fortunately represented in ex situ conservation programs (McFadden 
et al., 2013; Brannelly et al., 2015a, 2015b). Pseudophrynaminol, a synthesized alkaloid 
unique to this genus (Daly et al., 2005), does not inhibit the growth of B. subtilis, E. coli, 
or C. albicans (Macfoy et al., 2005) or elicit toxicosis in the fire ant S. invicta (Weldon et 
al., 2013), suggesting that its synthesized alkaloid defenses may not be particularly useful 
in inhibiting growth of pathogenic microbes and subsequently in facilitating successful 
reintroductions. However, since Pseudophryne spp. are also capable of sequestering 
pumiliotoxin alkaloids (Daly and Garraffo, 1990), future studies could assess whether 
sequestered alkaloids, or synthesized pseudophrynamines, are effective at inhibiting 
pathogens such as Bd, which may inform beneficial captive management strategies. 
Aside from the critically endangered Pseudophryne frogs, other species and populations 
of poison frogs are surely susceptible to pathogens. Future research could therefore 
include assessments of susceptibility from a wide range of lineages and populations of 
poison frogs. Electrical stimulation of granular glands to secrete alkaloids may be used as 
a minimally invasive field method of evaluating the composition and antimicrobial 
capacity of poison frog alkaloid defenses (Grant and Land, 2002; Daly et al., 2008a; 
Clark, 2010; Hantak et al., 2013). Overall, assessments of the antimicrobial efficacy of 
natural poison frog alkaloid defenses would undoubtedly be useful in determining 
prioritization strategies for conservation management of poison frogs now and in the 
future, when interactions between threats like continued habitat loss, climate change, and 
spreading infectious diseases may accelerate amphibian declines. 
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Research on synthesized amphibian chemical defenses in recent decades has 
developed our understanding of host-pathogen interactions extensively, but similar 
research on comparatively uncommon sequestered defenses such as alkaloids has just 
begun. Continued research is needed to examine relationships between sequestered 
poison frog alkaloid defenses and pathogens implicated in amphibian declines in order to 
determine which aspects of alkaloid defenses contribute most to growth inhibition, as 
well as to assess the practicality and efficacy of alkaloid provisioning for poison frogs of 
various life stages. Relevant pathogens to prioritize in such studies include Bd, 
ranaviruses, and water molds (Saprolegnia spp.), which are frequently observed in 
disease-induced mortality of amphibians in the field (Pessier, 2002; Prada-Salcedo et al., 
2011) and have been involved in peptide research (Rollins-Smith, 2009). Thus far, the 
majority of microbial inhibition research with amphibian chemical defenses has utilized 
OD assays to assess growth inhibition. Accordingly, comparisons between OD and CFU 
assay results in the present study may also inform experimental design decisions in future 
research. For instance, since certain populations of O. pumilio inhibited growth compared 
to control treatments in CFU assays but not in the preceding OD assays (Figs. 4 and 5), 
assessments of the antimicrobial efficacy of amphibian chemical defenses may require 
CFU assays following OD assays to accurately determine whether the compounds 
inhibited growth compared to control treatments. Conversely, since the relative patterns 
of growth inhibition among populations are nearly identical between OD assays and CFU 
assays for these pathogens (Figs. 4 and 5; Fig. 8), OD assays alone may be sufficient to 
estimate and compare the antimicrobial capacity of chemical defenses of different types 
or from various amphibian populations or taxa. 
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In the present study, results from these microbial growth inhibition assays serve 
as a step towards understanding whether poison frog alkaloid defenses may have evolved 
as a means of protection against pathogenic microbes. Much like variation in alkaloid 
defenses is hypothesized to play a role in defense against predators (Saporito et al., 2006, 
2007a; Murray et al., 2016), these findings suggest that the natural variation in poison 
frog alkaloid defenses influences protection from pathogenic microbes. As a result of 
comparable variation in dietary arthropods (Clark et al., 2006; Bonansea and Vaira, 2007; 
Daly et al., 2008a; Quiroga et al., 2011; Andriamaharavo et al., 2015), similar trends in 
microbial inhibition would likely be observed in other poison frog lineages, some of 
which are endangered due to threats such as continued habitat loss and spreading disease 
and would likely benefit from conservation management in captive breeding programs. 
Accordingly, findings from the present study may also be useful in improving 
conservation programs and strategies for poison frogs. 
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Table 1. The five most abundant alkaloids (in terms of relative quantity) identified in the 
skin of Oophaga pumilio from each population.  
 
Abbreviations for alkaloid classes are as follows: 3,5-P (3,5-disubstituted pyrrolizidine); 5,6,8-I (5,6,8-trisubstituted 
indolizidine); 5,8-I (5,8-disubstituted indolizidine); DHQ (decahydroquinoline); HTX (histrionicotoxin); Izi (izidine); 
Lehm (lehmizidine); Pyr (pyrrolidine); Tri (tricyclic); Unclass (unclassified). 
 
 
Population Arthropod source of alkaloids
Mites Ants
Structural 
class Alkaloid
Structural 
class Alkaloid
Tortuguero 5,6,8-I 251T, 223A 62%
5,8-I 247E, 205A, 207A
La Selva 5,8-I 207A, 195I Lehm 275A 48%
Unclass 311A, 209G
Finca los Nacientes 5,8-I 195I, 207A DHQ 269AB, 269A 46%
HTX 285C
Río Palmas Izi 209L 3,5-P 251K 28%
5,6,8-I 223A Pyr 197B
Tri 253S
Gandoca 5,8-I 251N Lehm 275A 57%
5,6,8-I 249C, 259C DHQ 195A
Percent of population's 
total alkaloids
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Table 2. Alkaloids detected in Oophaga pumilio arranged by structural class. 
1,4-Q 3,5-I 3,5-P 4,6-Q 5,6,8-I 5,8-I aPTX DHQ HTX Izidine Lehm Pip PTX Pyr Spiro Tri Unclass
231A 195B(2) 195F 237I 195G 195I(2) 241H 201A 193F 195A 283A(2) 193J 275A(5) 211I(2) 225F 183B 236 207GH(4) 167H
233A 223AB(2) 223B(3) 251Y 221P 203A 253A 203E 207O 211A 285A(5) 195K 277A(3) 211J 237A(2) 197B(5) 252A 207R 195N
257D(2) 223R 223H(3) 253X 221Q 205A(3) 267A 205L(2) 223F 285C(2) 209L(3) 225I(2) 265D 211T 219O 197K
259E 275C 249I(2) 265DD 223A(5) 207A(4) 293K(2) 221D 237U 287A(2) 211B(4) 239I(2) 277B 225P 221G 207N
279E 251K(3) 223C 207Q 309D(2) 221J 251A(2) 287B(3) 211F 239L(2) 307A(4) 235F 221M 209G(2)
251O 231B(3) 209I 323B 245F 267L(2) 291A 221N(2) 241D(4) 321A 253F 221W 211D
265J(3) 235E 209S 341A 265F(2) 269AB(6) 223I 241G(2) 323A(2) 253I 245J 223L
237C(2) 217B(3) 269A(2) 225G(2) 253J(2) 325B 267EE 247N 235I
237L(3) 219F(2) 269B(4) 239A 253U 277D(2) 249Z 235M
249C(4) 221I 271D(3) 239CC 267K(5) 277J 253S(5) 235S
251M(2) 223D(2) 275B(3) 247J(2) 267X(2) 279M 261C(2) 245R
251S 223J(2) 267BB 269C 261F 247L
251T(2) 223AA 291B 261H 247P
253H(4) 231C(3) 275L 247Q
259C(2) 231G 249N(2)
263A(4) 233D 251HH
265L(2) 235B(2) 261K
267J 237D(2) 261L
267CC 239G 265K
275E(6) 241F 267I
277E(2) 243B 267O(2)
279F 245I(3) 267Q(6)
293C 247E(2) 267DD
249O(2) 269E(3)
251N(2) 269K
259B 271E
261D(4) 273F
263F(2) 275M
265P 281U
271A 283I
273B(2) 291K
273C 311A
275F 323I(2)
Total 5 4 7 4 23 33 7 7 2 11 6 13 2 12 8 11 1 14 33 203
Dehydro-
5,8-I
Deoxy-
hPTX
 
Alkaloids present in quantities greater than 0.5 µg in at least one frog are listed, except in the case of new alkaloids (see Table 3). Alkaloids that are underlined represent 
tentatively new alkaloids that have not been previously described. Abbreviations for alkaloid classes are as follows: 1,4-Q (1,4-disubstituted quinolizidine); 3,5-I (3,5-disubstituted 
indolizidine); 3,5-P (3,5-disubstituted pyrrolizidine); 4,6-Q (4,6-disubstituted quinolizidine); 5,6,8-I (5,6,8-trisubstituted indolizidine); 5,8-I (5,8-disubstituted indolizidine); aPTX 
(allopumiliotoxin); Dehydro-5,8-I (dehydro-5,8-disubstituted indolizidine); Deoxy-hPTX (deoxy-homopumiliotoxin); DHQ (decahydroquinoline); HTX (histrionicotoxin); Lehm 
(lehmizidine); Pip (piperidine); PTX (pumiliotoxin); Pyr (pyrrolidine); Spiro (spiropyrrolizidine); Tri (tricyclic); Unclass (unclassified).
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Table 3. Retention times (Rt) for newly identified alkaloids from Oophaga pumilio (see 
Appendix 31 for mass spectral data). The Rt for each alkaloid is accompanied by an 
approximate "corrected Rt" that corresponds to the retention times in the alkaloid library 
of Daly et al. (2005). Following the methods of Garraffo et al. (2012), based on 
comparisons of Rts for previously identified alkaloids in the present study with Rts from 
Daly et al. (2005), alkaloids in the present study eluted approximately 0.34 seconds faster 
than times listed in Daly et al. (2005). 
Str. Class Alkaloid Rt Corrected Rt
Unclass 167H 5.67 5.33
Unclass 195N 7.53 7.19
Unclass 197K 7.37 7.03
Dehydro-5,8-I 203E 8.98 8.64
Pyr 225P 9.70 9.36
Unclass 245R 12.04 11.70
Unclass 247P 10.77 10.43
Unclass 247Q 11.69 11.35
Unclass 251HH 11.61 11.27
4,6-Q 253X 9.70 9.36
Unclass 261K 12.94 12.60
Unclass 261L 12.96 12.62
4,6-Q 265DD 13.30 12.96
Izi 267BB 12.65 12.31
5,6,8-I 267CC 12.80 12.46
Unclass 267DD 13.49 13.15
Pyr 267EE 14.40 14.06
Unclass 269K 11.38 11.04
Unclass 273F 14.88 14.54
Tri 275L 13.92 13.58
Unclass 275M 14.01 13.67
Pyr 277J 14.28 13.94
Pyr 279M 14.33 13.99
Unclass 281U 13.88 13.54
Unclass 283I 15.56 15.22
Unclass 291K 15.75 15.41
Unclass 311A 15.22 14.88
 
Abbreviations for alkaloid classes are as follows: 4,6-Q (4,6-disubstituted quinolizidine); 5,6,8-I (5,6,8-trisubstituted 
indolizidine); Dehydro-5,8-I (dehydro-5,8-disubstituted indolizidine); Izi (izidine); Pyr (pyrrolidine); Tri (tricyclic); 
Unclass (unclassified). 
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Table 4. Diversity (alkaloids per frog skin) and quantity (µg per frog skin) of alkaloid 
defenses from each population of Oophaga pumilio. 
Average 
diversity
Average ♀ 
diversity
Average ♂ 
diversity
Total 
diversity
Total ♀ 
diversity
Total ♂ 
diversity
Tortuguero 37 39 36 521 272 249
La Selva 33 36 30 458 250 208
Finca los Nacientes 54 55 53 758 441 317
Río Palmas 39 42 36 548 334 214
Gandoca 26 21 31 364 147 217
All populations 38 39 37 2649 1444 1205
Average 
quantity
Average ♀ 
quantity 
Average ♂ 
quantity
Total 
quantity
Total ♀ 
quantity
Total ♂ 
quantity
Tortuguero 986 1224 748 13807 8567 5239
La Selva 344 462 225 4811 3233 1578
Finca los Nacientes 1181 1219 1130 16528 9750 6778
Río Palmas 264 295 223 3697 2357 1340
Gandoca 344 280 524 4812 1148 3665
All populations 624 677 564 43656 25056 18600
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Figure 1. Map of five Oophaga pumilio collection sites in Costa Rica. 
  
79 
 
 
 
Figure 2. MDS plots [(a) original MDS plot; (b) scaled to quantity)] of alkaloid 
composition for five populations of Oophaga pumilio. Each point represents an 
individual frog (70 frogs total, 14 per population). The distance between symbols 
represents differences in alkaloid composition (number, type, and quantity of alkaloids 
per frog skin; in (b) the diameter of each point is scaled to quantity of alkaloids per frog, 
and La Selva frogs are encircled by a dotted line to distinguish them from nearby points). 
Points that are closer together represent frogs that have more similar alkaloid profiles, 
whereas points that are further apart represent frogs with less similar alkaloid profiles. 
a 
b 
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● Tortuguero     ■ La Selva     ▲ Finca los Nacientes     ♦ Rίo Palmas     ▼ Gandoca 
 
Figure 3. Relationship between alkaloid quantity (µg per frog skin) and diversity 
(alkaloids per frog skin) in Oophaga pumilio from five populations throughout Costa 
Rica. 
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Figure 4. Mean final optical densities (OD620) (a) and viable cell densities (CFU/mL) (b) 
of Aeromonas hydrophila after treatment with alkaloid cocktails extracted from Oophaga 
pumilio. The dotted line represents the mean OD620 and CFU/mL for the methanol 
control, error bars represent ± 1 standard error of the mean, and treatment means that are 
significantly different from each other are indicated by different letters (Tukey’s HSD, p 
< 0.05). 
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Figure 5. Mean final optical densities (OD620) (a) and viable cell densities (CFU/mL) (b) 
of Klebsiella pneumoniae after treatment with alkaloid cocktails extracted from Oophaga 
pumilio. The dotted line represents the mean OD620 and CFU/mL for the methanol 
control, error bars represent ± 1 standard error of the mean, and treatment means that are 
significantly different from each other are indicated by different letters (Tukey’s HSD, p 
< 0.05). 
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● Tortuguero     ■ La Selva     ▲ Finca los Nacientes     ♦ Rίo Palmas     ▼ Gandoca 
 
Figure 6. Relationship between alkaloid profiles of individual Oophaga pumilio and 
corresponding growth inhibition of Aeromonas hydrophila [(a) alkaloid diversity 
(alkaloids per frog skin) and optical density assay; (b) alkaloid diversity (alkaloids per 
frog skin) and colony-forming unit assay; (c) alkaloid quantity (µg per frog skin) and 
optical density assay; (d) alkaloid quantity (µg per frog skin) and colony-forming unit 
assay]. 
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● Tortuguero     ■ La Selva     ▲ Finca los Nacientes     ♦ Rίo Palmas     ▼ Gandoca 
 
Figure 7. Relationship between alkaloid profiles of individual Oophaga pumilio and 
corresponding growth inhibition of Klebsiella pneumoniae [(a) alkaloid diversity 
(alkaloids per frog skin) and optical density assay; (b) alkaloid diversity (alkaloids per 
frog skin) and colony-forming unit assay; (c) alkaloid quantity (µg per frog skin) and 
optical density assay; (d) alkaloid quantity (µg per frog skin) and colony-forming unit 
assay].  
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● Tortuguero     ■ La Selva     ▲ Finca los Nacientes     ♦ Rίo Palmas     ▼ Gandoca 
 
Figure 8. Relationship between optical density and colony-forming unit assays for (a) 
Aeromonas hydrophila and (b) Klebsiella pneumoniae treated with alkaloids extracted 
from Oophaga pumilio. 
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APPENDIX 
Cryopreservation of Microbes 
Upon receipt of Aeromonas hydrophila (ATCC® 35654™) and Klebsiella pneumoniae 
subsp. pneumoniae (ATCC® 13883™), 30 mL TSB stock cultures were grown in 50 mL 
conical tubes and incubated for 24 hours at 30°C (A. hydrophila) or 37°C (K. 
pneumoniae) in a shaking incubator set to 100 rpm. Twelve 1 mL frozen stock cultures 
were created from the initial 30 mL cultures by adding 900 µL of the culture to 100 µL 
sterile 80% glycerol in each of twelve labeled cryovials. Frozen stock cultures were 
stored at -80°C until use in assays. 
 
Pilot Experiments 
A variety of preliminary pilot experiments were conducted to determine optimal dilutions 
and corresponding growth curves of microbial cultures for use in microbial growth 
inhibition assays, and to examine the effect that various volumes of the vehicle control 
(methanol) had on the growth of each microbe. 
 
Effect of Methanol on Growth of Various Dilutions of Bacterial Cultures 
Aeromonas hydrophila OD Pilot Assays 
A 30 mL culture of A. hydrophila was grown from an isolated colony on a streak plate 
and incubated at 30°C with agitation at 100 rpm for 18 hours. Three 10 mL dilutions (1:5, 
1:10, and 1:50) were created from this 30 mL culture. For the 1:5 dilution, 2 mL of A. 
hydrophila culture was added to 8 mL TSB. For the 1:10 dilution, 1 mL A. hydrophila 
culture was added to 9 mL broth. For the 1:50 dilution, 0.2 mL of A. hydrophila culture 
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was added to 9.8 mL broth. All dilutions were vortexed for five seconds and then poured 
into individual plastic troughs immediately prior to transferring aliquots to 96-well 
microplates. Equal 200 µL volumes (subcultures) of each dilution were immediately 
plated in a 96-well microplate such that each dilution occupied three columns of eight 
replicate wells each (total nine columns used per pilot assay). The eight replicate wells in 
the first of three columns of each of the 1:5, 1:10, and 1:50 dilutions acted as the negative 
control and were not inoculated, which created a typical growth curve for A. hydrophila 
alone at each dilution. The eight wells in the second columns of each dilution were 
inoculated with 5 µL of methanol as a proxy for estimating the effect of 4.8 µL of 
methanol on growth of A. hydrophila. The eight wells in the third columns of each 
dilution were inoculated with 10 µL of methanol as a proxy for estimating the effect of 
9.6 µL of methanol on growth of A. hydrophila. After preparation, the microplate was 
placed in the microplate reader and OD620 was measured over the course of a 24.5-hour 
program that recorded OD620 at 15-minute intervals and shook the plate at medium speed 
for five seconds prior to each measurement. All eight OD620 measurements for replicate 
wells for each of the nine treatments were treated as subsamples and were averaged to 
visualize growth curves. 
This pilot assay was conducted twice to verify the repeatability of the results. In 
both assays, identical trends in A. hydrophila growth were observed (Appendix 1). The 
1:5 and 1:10 dilutions were clearly in mid-log growth phase at the start of the assay and 
had nearly overlapping growth curves when inoculated with no methanol and 5 µL 
methanol, although the 1:5 dilution had a slightly higher OD620 throughout the 24.5-hour 
growth period. The 1:50 dilution entered log growth phase after a slight (< 1 hour) delay 
88 
compared to the 1:5 and 1:10 dilutions, and had a reduced OD620 after 24.5 hours in 
comparison to the 1:5 and 1:50 dilutions. When inoculated with 10 µL methanol, all 
dilutions went through a 10 – 12 hour lag phase before entering log growth phase, and 
grew to a maximum OD620 nearly half that of all other growth curves; this suggested that 
10 µL methanol was not a feasible vehicle control volume to use in OD assays. 
Therefore, a pilot experiment comparing 5 µL methanol and 7.5 µL methanol was 
conducted. 
The above procedure was carried out identically for this third pilot assay, but 7.5 
µL methanol was used in place of 10 µL methanol. Growth curves for the 1:5, 1:10, and 
1:50 dilutions of A. hydrophila were identical to the previous pilot assays in treatments 
when not inoculated with methanol and when inoculated with 5 µL, but the addition of 
7.5 µL methanol still delayed log growth by 3 – 5 hours and reduced the final OD620 by 
nearly half (Appendix 2). Therefore, 7.5 µL was determined to be an unsuitable vehicle 
control volume to use in OD assays, and a pilot assay examining the effect of 2.4 µL 
methanol and 4.8 methanol on growth at each of the three previous dilutions was 
conducted.  
Using the above procedures, growth curves of A. hydrophila at 1:5, 1:10, and 1:50 
dilutions were identical to those in previous pilots in the absence of methanol and when 
inoculated with 4.8 µL methanol (Appendix 3). Moreover, growth curves of A. 
hydrophila inoculated with 2.4 µL methanol were very similar to growth curves of A. 
hydrophila that had not been inoculated with methanol, which indicated that this volume 
is ideal for a vehicle control in growth inhibition assays. Based on these growth curves, 
the 1:10 dilution was determined to be most suitable for growth inhibition assays since it 
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started at an intermediate OD620 compared to 1:5 and 1:50 dilutions and appeared to start 
at the very beginning of log growth phase in each assay, thereby providing the most 
appropriate growth curve with which to assess growth inhibition due to alkaloids. Since 
growth curves of A. hydrophila inoculated with 4.8 µL methanol were somewhat 
inhibited compared to A. hydrophila not inoculated with methanol, a pilot assay was 
conducted to determine whether or not adding methanol in the mid-log phase (after a 1.5 
hour delay) would change rates of growth at the mid-log phase in the 1:10 dilution of A. 
hydrophila. 
In this pilot assay, A. hydrophila was cultured and diluted following the same 
procedure as previous pilots, but the 1:10 dilution of A. hydrophila was examined under 
five conditions in triplicate: no methanol, 2.4 µL methanol added prior to measurements, 
4.8 µL methanol added prior to measurements, 2.4 µL methanol added 1.5 hours after 
starting the assay, and 4.8 µL methanol added 1.5 hours after starting the assay. 
Measurements were recorded for a total of 4.25 hours, which is when log phase growth 
tended to stop in previous pilot assays. The results suggest that adding methanol after a 
1.5-hour delay caused growth after 4.25 hours to be nearer in OD620 to growth in the 
absence of methanol in comparison to methanol added at the beginning of the assay 
(Appendix 4). This is supported by the observation that, at 1.5 hours, growth curves of A. 
hydrophila with methanol added initially were lower in OD620 than A. hydrophila in the 
other three treatments that did not contain methanol at that point. Until the addition of 
methanol 1.5 hours into the assay, the other three treatments overlapped almost exactly. 
Interestingly, the addition of 2.4 µL methanol before assays seemed to cause an increase 
in growth of A. hydrophila after 2.4 hours. 
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In order to determine whether or not a similar effect would occur if natural frog 
alkaloids were added after a 1.5-hour delay, this pilot was replicated with the addition of 
two more treatments: 4.8 µL of alkaloids in methanol from frog GAN-2F (female frog 
collected from Gandoca) after a 1.5-hour delay and 4.8 µL of alkaloids in methanol from 
frog GAN-3F (female frog from Gandoca) after a 1.5-hour delay. These two frogs were 
selected for this pilot because they had the widest variation in alkaloid quantity of frogs 
available at that point in the experiment (414 µg vs. 45 µg per frog skin). Following the 
procedure from the previous pilot assay, nearly identical results were obtained with the 
addition of the two 4.8 µL alkaloid treatments (Appendix 5). Growth of A. hydrophila 
that was inoculated with methanol after a 1.5-hour delay was slightly closer in OD620 to 
that of A. hydrophila in the absence of methanol, and 2.4 µL methanol added prior to the 
assay caused a slight increase in OD620 after 4.25 hours. Delayed addition of 4.8 µL 
alkaloids in methanol from GAN-2F, which contained a significantly higher quantity of 
alkaloids than GAN-3F, caused OD620 to be lower after 4.25 hours in comparison to 
delayed addition of 4.8 µL methanol alone. Delayed addition of 4.8 µL alkaloids in 
methanol from GAN-3F resulted in OD620 similar to delayed addition of methanol alone, 
though still lower than growth of A. hydrophila in the absence of methanol. These results 
suggest that alkaloids from frogs with a relatively high quantity of alkaloids may inhibit 
growth, while frogs with relatively small quantities of alkaloids may not show inhibition 
compared to the vehicle control. Inoculation of methanol and alkaloids prior to beginning 
assays was ultimately selected as the most appropriate procedure since the delayed 
addition of treatments required removing the microplate from the microplate reader and a 
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45-minute period of inoculating subsamples with methanol and alkaloids during which 
the subsamples would grow exponentially. 
Lastly, to verify that the addition of alkaloids inhibited growth after 24.5 hours 
compared to methanol alone, a pilot assay was conducted using triplicate subsamples of 
1:10 diluted A. hydrophila in seven treatments: absence of methanol, 2.4 µL methanol, 
4.8 µL methanol, 2.4 µL alkaloids from GAN-1F (female frog from Gandoca), 4.8 µL 
alkaloids from GAN-1F, 2.4 µL alkaloids from GAN-2M (male frog from Gandoca), and 
4.8 µL alkaloids from GAN-2M. GAN-1F and GAN-2M were selected because they 
differed in alkaloid quantity, with GAN-1F (280 µg) having a lower quantity of alkaloids 
compared to GAN-2M (421 µg). Different frogs from the previous pilot were used in 
order to limit the quantity of alkaloids used from individual frogs, given the limited 
amount of frog alkaloids available for the experiment. The results from this pilot assay 
are in line with previous pilots in that 2.4 µL methanol did not inhibit growth 
significantly compared to untreated A. hydrophila (Appendix 6). The results also indicate 
that frogs with relatively high quantities of alkaloids (GAN-2M in this case) inhibit 
growth of A. hydrophila compared to methanol alone and compared to frogs with 
relatively low quantities of alkaloids (GAN-1F here). This is most apparent in volumes of 
2.4 µL, where alkaloids from GAN-2M were visibly more inhibitory than methanol and 
alkaloids from GAN-1F. Although alkaloid inhibition may not be as apparent at volumes 
of 4.8 µL, both frogs’ alkaloids resulted in OD620 measurements that were slightly below 
growth with 4.8 µL methanol alone. 
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Aeromonas hydrophila CFU Pilot Assays 
In order to determine the number of serial dilutions required to obtain single colonies 
from growing 10 µL aliquots of Aeromonas hydrophila on TSA, pilot CFU assays were 
conducted following the first five pilots, including four 24.5-hour OD pilot assays and the 
first pilot examining mid-log addition of treatments. In the first four pilots, two 
subsamples of each treatment were serially diluted seven times and plated on TSA in 10 
µL aliquots. In the fifth pilot, all three subsamples used were serially diluted seven times 
and then plated on TSA in 10 µL aliquots. The overall conclusion from serial dilution 
pilots is that a minimum of six serial dilutions is generally required to observe single 
colonies below 30 CFUs per aliquot. Additionally, greater volumes of methanol appear to 
result in lower CFU counts, suggesting that viability of A. hydrophila cells decreases with 
exposure to methanol, which is consistent with results from pilot OD assays. Regarding 
CFU counts for the fifth pilot, which compared initial addition and mid-log addition of 
2.4 µL and 4.8 µL methanol, the average CFU count parallels trends in the OD assay 
almost exactly: mid-log addition of methanol resulted in growth comparable to growth in 
the absence of methanol, while initial addition of 2.4 µL methanol resulted in increased 
growth and initial addition of 4.8 µL methanol resulted in decreased growth (Appendix 4 
and 7). 
 
Klebsiella pneumoniae OD Pilot Assays 
Three replicated pilot assays comparing growth curves of 1:5, 1:10, and 1:50 dilutions in 
the absence of methanol, with 2.4 µL methanol, and with 4.8 µL methanol were carried 
out to determine the optimal dilution of K. pneumoniae to use in OD assays with 
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alkaloids. Similarly to previous pilot OD assays with A. hydrophila, eight 200 µL 
subsamples for each treatment were plated in a microplate and OD620 was measured at 
15-minute intervals over 24.5 hours. All three pilot assays produced nearly identical 
growth curves for each treatment at each dilution (Appendix 8). Similar to pilot results 
with A. hydrophila, the 1:5 dilution treatments began and ended with the highest OD620, 
the 1:10 dilution began and ended intermediately at OD620, and the 1:50 dilution began 
and ended with the lowest OD620 values. Once again, a dose-response relationship was 
observed with methanol treatments, where the addition of 4.8 µL methanol reduced 
OD620 more than 2.4 µL methanol after 24.5 hours. At all dilutions, the addition of 2.4 µL 
methanol appears to reduce OD620 compared to treatments with no methanol added, 
which was not always apparent with A. hydrophila. Growth curves of the 1:50 dilution 
appeared to start just prior to log phase, which made it the least ideal for growth 
inhibition assays of the three dilutions. Between the 1:5 and 1:10 dilutions, the 1:5 
dilution was selected for use in assays with alkaloids on the grounds that its growth curve 
after 24.5 hours was nearer to leveling off (stationary phase) than the 1:10 dilution. Pilot 
CFU assays also played a role in selecting the 1:10 dilution for alkaloid assays. In 
practice, using either of the 1:5 or 1:10 dilutions did not make a difference in terms of 
growth inhibition results. 
 
Klebsiella pneumoniae CFU Pilot Assays 
Pilot CFU assays were carried out immediately following pilot OD assays for K. 
pneumoniae, and similar trends were observed to those in A. hydrophila pilot CFU 
assays. CFUs from 1:5 dilutions consistently required seven serial dilutions in the 
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absence of methanol and with the addition of both 2.4 µL and 4.8 µL methanol. The 1:10 
dilution yielded CFUs below 30 in number only when methanol was added, but not in 
every case, and the 1:50 dilution showed considerable variation around which serial 
dilution yielded CFUs under 30 in number. Therefore, the 1:5 dilution was selected as 
most suitable for growth inhibition assays because the number of required serial dilutions 
was consistent and most similar to those conducted in A. hydrophila assays. Moreover, 
since the magnitude of difference between serial dilutions was factored into the original 
cell density equations used to report CFU assay results, using the 1:5 resulted in the least 
potential variation in original cell density. 
 
Batrachochytrium dendrobatidis (Chytrid Fungus) Culture and Pilots 
Culture and Maintenance of Batrachochytrium dendrobatidis 
Batrachochytrium dendrobatidis (JEL 197, type strain isolated from an infected green 
and black poison frog (Dendrobates auratus) (Longcore et al., 1999)) was received from 
Alessandro Catenazzi (Southern Illinois University, Carbondale) on 1% tryptone agar. 
Main stock cultures were grown in 1% tryptone broth (Fisher BioReagents, Thermo 
Fisher Scientific, Waltham, MA) at 20°C – 22°C for ten days and then stored at 4°C. 
Stock cultures (500 mL) were passaged monthly. 
For pilot assays, working stocks were produced by growing aliquots of stock Bd 
cultures in 1% tryptone broth in 50 mL conical tubes for under one week to ensure that 
cells were in an active phase of growth. When isolating zoospores from zoosporangia, 2 – 
3 mL of working stock broth cultures were added to 1% tryptone agar in petri dishes 
(Fisherbrand, Thermo Fisher Scientific, Waltham, MA). Inoculated dishes were left open 
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in the laminar flow hood for 45 – 60 minutes, or until the broth had almost entirely 
evaporated. Dishes were then sealed with Parafilm® M (American National Can, 
Chicago, IL) and incubated at 20°C – 22°C for 3 – 7 days. 
Active zoospores were identified by inverting the dishes on a compound 
microscope (Olympus CX21, Olympus, Center Valley, PA) and examining with the 10X 
objective. Zoospores were harvested by flooding 3 – 7 day old inoculated dishes with 2 – 
3 mL sterile 1% tryptone broth or deionized water for 30 minutes. The solution 
containing active zoospores was then passed over sterile nylon mesh filters (20 µm) to 
remove zoosporangia. Bd zoospores were intended to be assayed as opposed to a solution 
containing both zoospores and mature zoosporangia, because zoospores are the infectious 
stage of Bd (Berger et al. 2005) and would be the first to come into contact with alkaloid-
based defenses of poison frogs. Therefore, alkaloid-zoospore assays are the most 
appropriate first step towards studying the ecological interactions of Bd with alkaloids. 
Zoospores were counted using a hemacytometer (Reichert-Jung Bright-Line, Hausser 
Scientific, Horsham, PA). 
The first pilot for Bd sought to determine a typical growth curve of the unfiltered 
1% tryptone broth culture in the absence of methanol, with 2.4 µL methanol, and with 4.8 
µL methanol. Similarly to pilot OD assays with bacteria, 200 µL subsamples of 1:5 
diluted Bd from a main stock were plated in a microplate with eight subsamples per 
treatment: two control samples (i.e., two columns with eight replicates each) of Bd in the 
absence of methanol, one sample of Bd inoculated with 2.4 µL methanol, and one sample 
of Bd inoculated with 4.8 µL methanol. Optical density measurement filters on the Fisher 
Scientific Multiskan FC microplate reader allowed measurement at 405 nm, 450 nm, 550 
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nm, and 620 nm; the lowest (OD405) and highest (OD620) wavelengths were used to 
measure growth. Due to the prolonged growth period of Bd, this assay ran for seven days; 
since the microplate reader is limited to 100 measurements per assay, seven consecutive 
runs of 24-hour programs that measured OD405 and OD620 at 15-minute intervals were 
carried out. Based on the optical density measurements over seven days (Appendix 9), 
growth of Bd at this dilution is clearly very slow, and would undoubtedly have continued 
to increase past the end of this assay (as shown in the second Bd pilot). Methanol also 
clearly inhibits the growth of Bd, and there is an evident dose-response relationship 
between inoculation with 2.4 µL and 4.8 µL methanol. Additionally, there are regular 
four- to six-hour fluctuations in OD throughout the assay, although this does not appear 
to be typical in Bd growth (Alessandro Catenazzi, pers. comm.). Finally, the growth 
curves of replicate treatments measured at 405 nm and 620 nm showed identical growth 
patterns, but OD measurements at lower wavelengths seemed to distinguish greater 
differences between treatments. As a result, 405 nm was selected as the ideal wavelength 
to use in OD assays with Bd. However, most antimicrobial peptide assays with Bd use a 
492 nm wavelength filter for similar OD assays, which were unavailable, so it may be 
worthwhile to locate a 492 nm filter for the Fisher Scientific Multiskan FC microplate 
reader. 
In order to characterize the growth of Bd after one week, the treatments for the 
first pilot experiment was replicated and Bd growth was measured over the course of 14 
days. The program measured OD405 at 4-hour intervals. The results of this second pilot 
showed a very similar growth pattern in which growth starts to become noticeable 
between 72 and 96 hours (Appendix 10) suggest that Bd growth curves can be relatively 
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consistent. However, the initial OD405 was slightly reduced compared to initial OD405 in 
the first pilot (about 0.12 OD compared to 0.13 OD), and this difference appears to be 
retained in similar proportion at the end of the assay. For example, in this second pilot, 
the OD405 after 168 hours was about 0.19 for non-methanol treatments and 0.25 at the end 
of the second pilot (i.e., after 336 hours), whereas OD405 for the same treatments in the 
first pilot after 168 hours was nearly 0.23. Clearly, small differences in OD at the outset 
of Bd assays can result in substantial differences in growth after one and two weeks, 
which has the potential to confound comparisons between different assays. Moreover, 
since Bd grows so slowly, maintaining a consistent starting OD is likely the primary 
methodological challenge, especially if using only zoospores. 
Bd zoospores were successfully isolated from cultured zoosporangia and counted 
on a hemacytometer, although no growth curves were generated from exploratory 
experiments. A variety of methodological difficulties were encountered throughout pilot 
experimentation with Bd. For example, the culture media (1% tryptone) was determined 
to react with iodine used in killing and staining of motile zoospores, which is highly 
useful in counting zoospores to estimate the quantity of zoospores per mL solution. The 
reaction between tryptone and iodine produced dense clouds of red-brown, rapidly-
vibrating objects that were several times larger than zoospores, but also gradually 
reduced their movement and settled onto the hemacytometer surface as if they had been 
stained and killed. This reaction did not occur between iodine and sterile water, however, 
which would likely be the best solution to count zoospores in. Alternatively, there are a 
variety of other dyes available (e.g., trypan blue, although only dead zoospores absorb the 
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dye (McMahon and Rohr, 2014)) that may be worthwhile to invest in for counting 
zoospores. 
Zoospores were rarely isolated in densities exceeding 5 × 105 zoospores/mL, 
which is near the lower limit for accurate counting on the hemacytometer. To acquire 
higher zoospore densities, denser mats of Bd zoosporangia on multiple agar plates (but no 
more than 20 should be fit in the hood, spread out with lids off) must be cultured. 
Accordingly, liquid cultures of Bd must also be dense but in an active phase of growth; it 
may be useful to plate the settled zoosporangia from liquid cultures, as opposed to 
agitating the culture before removing zoosporangia. Similarly, working cultures likely do 
not need to be diluted much (e.g., 1:10 in first two Bd pilot experiments).  
99 
 
Appendix 1. Growth curves of Aeromonas hydrophila from (a) pilot experiment 1 and 
(b) pilot experiment 2. Cultures diluted to 1:5, 1:10, and 1:50 had 0 µL, 5 µL, or 10 µL 
methanol added. OD620 measurements were recorded at 15-minute intervals over the 
course of 24.5 hours. 
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Appendix 2. Growth curves of Aeromonas hydrophila from pilot experiment 3. Cultures 
diluted to 1:5, 1:10, and 1:50 had 0 µL, 5 µL, or 7.5 µL methanol added. OD620 
measurements were recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 3. Growth curves of Aeromonas hydrophila from pilot experiment 4. Cultures 
diluted to 1:5, 1:10, and 1:50 had 0 µL, 2.4 µL, or 4.8 µL methanol added. OD620 
measurements were recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 4. Growth curves of Aeromonas hydrophila from pilot experiment 5. Cultures 
diluted to 1:10 had 0 µL, 2.4 µL, or 4.8 µL methanol added initially or after 1.5 hours of 
incubation (“mid-log”). OD620 measurements were recorded at 15-minute intervals over 
the course of 24.5 hours. The dotted line represents the point at which mid-log treatments 
were added. 
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Appendix 5. Growth curves of Aeromonas hydrophila from pilot experiment 6. Cultures 
diluted to 1:10 had 0 µL, 2.4 µL, or 4.8 µL methanol or Oophaga pumilio alkaloids 
added initially or after 1.5 hours of incubation (“mid-log”). OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. The dotted line represents 
the point at which mid-log treatments were added. 
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Appendix 6. Growth curves of Aeromonas hydrophila from pilot experiment 7. Cultures 
diluted to 1:10 had 0 µL, 2.4 µL, or 4.8 µL methanol or Oophaga pumilio alkaloids 
added. OD620 measurements were recorded at 15-minute intervals over the course of 24.5 
hours. The dotted line represents the point at which mid-log treatments were added. 
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Appendix 7. Mean colonies formed per 10 µL aliquot from treatments within Aeromonas 
hydrophila pilot experiment 5 (1:10 diluted initial culture). Error bars represent ± 1 
standard error of the mean, based on three replicates per treatment.  
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Appendix 8. Growth curves of Klebsiella pneumoniae from (a) pilot experiment 1, (b) 
pilot experiment 2, and (c) pilot experiment 3. Cultures diluted to 1:10 had 0 µL, 2.4 µL, 
or 4.8 µL methanol added initially. OD620 measurements were recorded at 15-minute 
intervals over the course of 24.5 hours. 
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Appendix 9. Growth curves of Batrachochytrium dendrobatidis from pilot experiment 1. 
Cultures diluted to 1:5 had 0 µL, 2.4 µL, or 4.8 µL methanol added initially. OD405 and 
OD620 measurements were recorded at 1-hour intervals over the course of 7 days. 
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Appendix 10. Growth curves of Batrachochytrium dendrobatidis from pilot experiment 
2. Cultures diluted to 1:5 had 0 µL, 2.4 µL, or 4.8 µL methanol added initially. OD405 
measurements were recorded at 4-hour intervals over the course of 14 days. 
 
  
108 
Appendix 11. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
Appendix 12. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 13. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 14. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 15. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements 
were recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 16. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements 
were recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 17. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 18. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 19. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
 Appendix 20. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 21. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 22. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 23. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 24. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 25. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements 
were recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 26. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements 
were recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 27. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours 
 
 
Appendix 28. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 29. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
 
 
Appendix 30. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b) 
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were 
recorded at 15-minute intervals over the course of 24.5 hours. 
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Appendix 31. Mass spectral data for the 27 new alkaloids detected in Oophaga pumilio 
(Table 3). The Rt for each alkaloid is included, along with an approximate “corrected Rt” 
to match the retention times in the alkaloid library of Daly et al. (2005). Following the 
methods of Garraffo et al. (2012), based on comparisons of Rts for previously identified 
alkaloids in the present study with Rts from Daly et al. (2005), alkaloids in the present 
study eluted approximately 0.34 seconds faster than times listed in Daly et al. (2005). 
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